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double antibody sandwich ELISA or in immunofluorescence. This shows the potential of the 
phage display system in obtaining antibodies that are suitable for routine diagnosis without 
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Chapter 1 
General introduction 
In the early days of agriculture crops were small, biodiversity was high and trade was limited. 
This situation gave plant pathogens only a limited chance to spread and to cause significant 
damage. However, as time past by, crops were covering larger areas. This, while the genetic 
homogeneity within the crops was increasing. In combination with the increasing trade, the 
application of monocultures in today's agriculture has resulted in the outbreak of many 
devastating plant diseases. The economic damage of diseases and pests, caused by viroids, 
viruses, bacteria, insects, fungi and plant-parasitic nematodes is gigantic. Indirect losses are 
difficult to assess because the presence of certain pathogens or plague organisms in 
productive soils discourages the cultivation of economically important plants. 
Pathogens can be carried on, or in plant propagation material and a disease can become 
manifest when the crop starts to grow. Even when transmission rates are low, sufficient 
inoculum may be present for an epidemic outbreak. Certification of healthy plant propagation 
material is of major importance to avoid the spread of various diseases to regions where a 
particular plant-pathogen is absent. Moreover, the information obtained from general surveys, 
on the presence of plant-pathogens in or on crops or in soil, can be used for advisory systems 
with regard to crop rotation, cultivar selection, pesticide application, harvest dates, post 
harvest handling, etc. 
Detection and identification 
The earliest form of plant-pathogen diagnosis was based on the recognition of specific 
symptoms in crop plants. Because many pathogens do not produce specific symptoms in their 
hosts or are latently present, the development of alternative methods to confirm the identity of 
the causal agent is required. These assays should be robust, uncomplicated and fast. 
Transmission to indicator host plants, plating on selective media, microscopy, 
chromatography and electrophoresis often provide valuable information and are still widely 
used as methods for the identification and detection of plant-pathogens. However, they are 
laborious and it may take up to weeks before a result is obtained. Modern molecular 
techniques such as the polymerase chain reaction [58] and nucleic acid sequence based 
amplification [35] are fast and can be used as a reliable tool to detect various plant-pathogens 
[62,77]. Although both are sensitive methods, they are not suited yet for testing the large 
numbers that have to be tested annually (over 2 million samples in the Netherlands alone) for 
the certification of plant propagation material. In contrast, serological assays form a good 
compromise between robustness, sensitivity, specificity on one hand and ease and expense of 
application on the other hand. 
Serological assays 
The first report describing the use of serology for the identification of a plant-pathogenic 
bacterium was published in 1918 [31], when Jensen used an antiserum in an agglutination test 
showing that a strain of Agrobacterium tumefaciens from Denmark could be differentiated 
from a strain from the United States. During the 1930s, agglutination assays rapidly became 
popular for identification of plant-pathogenic bacteria and viruses, and remain so today. After 
the introduction of the agar double diffusion test by Ouchterlony [51], agar precipitin tests 
became widely used during the 1950s for identification of medically important bacteria. 
However, Ouchterlony double diffusion was not applied for identification of plant-pathogenic 
bacteria until 1960, when Lovrekovich and Klement [39] reported that species-specific 
antigens of Pseudomonas tabaci could be detected in Ouchterlony double diffusion tests but 
not in agglutination assays. Immunofluorescent (IF) staining was suggested in 1943 [52] for 
identification of bacteria in plants. However, no further interest was shown until 1965 when 
Morton [45] reported the superiority of direct IF over agglutination tests for rapid 
identification of the bacterium Xanthomonas vesicatoria. The development of the enzyme-
linked immunosorbent assay (ELISA) by Van Weemen and co-workers [71] started a new era 
in direct detection of infectious agents. A few years after its development, this technique was 
also applied for the diagnosis of plant viruses [14]. 
The development of antisera against plant viruses has been very successful. In 1984, over 
300 different virus species could be detected with specific immunoassays [69,70]. However, 
raising antisera specific for plant-parasitic nematode species, plant-pathogenic fungi and 
bacteria proved more difficult. Cross-reactions were generally observed with other nematode 
species [78], saprophytic fungi [9] and closely related bacteria [44,68]. These problems can be 
ascribed to the variation in antibodies within a polyclonal antiserum. 
Immune selection and the generation of polyclonal antibodies 
The ability to respond to an apparently unlimited array of foreign antigens is one of the 
most remarkable features of the vertebrate immune system. Almost all antibody molecules 
contain a unique stretch of amino acids in their variable region (Fig. 1.1). This diversity is 
generated during B-lymphocyte differentiation (Fig. 1.2) in the bone marrow, where antibody 
encoding gene segments are randomly shuffled by a carefully regulated dynamic genetic 
system [27]. 
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Figure 1.1. A model for the structure of a mouse antibody molecule, composed of two light and two 
heavy polypeptide chains. Two identical antigen-binding sites, formed by the variable regions of the 
heavy chain (VH) and light chain (VL), are located at one side of the antibody molecule. The constant 
regions of the light chain (CL), the constant domains of the heavy chain (CH1, CH2, CH3), interchain 
and intrachain disulfide bonds (S-S) are indicated. The Fv and Fab fragments of the antibody molecule 
are surrounded by dotted lines, whereas the organization of the variable domains in framework regions 
(FR) and complementarity determining regions (CDR) is shown in more detail within the box. 
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Figure 1.2. Sequence of rearrangements of immunoglobulin heavy chain genes involved in the 
formation of messenger RNA. The first rearrangement involves the recombination of V (variable), J 
(Joining) and in case of the heavy chain also D (Diversity) gene segments, so that rearranged VDJ 
genes are produced. In the primary RNA transcript the C region genes (Cu and C8) remain separated 
from the VDJ complexes by introns. These introns are removed by RNA splicing to produce 
functional messenger RNAs for the u heavy chain. Formation of light chain mRNA follows an 
essentially similar sequence, except that the D genes are absent (not shown). 
Combinatorial joining of germline gene segments and two additional phenomena are active 
during this process: junctional flexibility and N-region nucleotide addition. The result is a 
mature immunocompetent B-lymphocyte, which contains a single functional DNA sequence 
encoding the heavy-chain variable-region (VH) and a single DNA sequence encoding the 
light-chain variable-region (VL). It is anticipated that the immune system is capable of 
generating more than 108 different antibody molecules (Table 1.1) without ever being 
exposed to foreign antigens. Upon antigenic stimulation this number is further increased 
(Table 1.1) by somatic hypermutation of the complementary determining regions in the VL 
and VH domains to at least 1010 different molecules [36]. 
Most plant-pathogens are complex mixtures and consist of multiple antigens containing 
two or more epitopes (antigenic determinants). These mixtures of antigens will cause clonal 
expansion of different T- and B-lymphocytes when injected into animals, (immunization). 
The resulting immune response is polyclonal and, in addition, polyepitopic [3]. As many 
epitopes are shared by related genera or species, cross-reactions can hardly be avoided when 
polyclonal antibodies are used in detection assays. 
Table 1.1. The mechanisms generating the diversity in mouse antibodies. Combinatorial joining of 
germline antibody gene segments i.e., the variable regions of the light chain (VL) and the heavy chain 
(VH), the Diversity (D) and Joining (J) gene segments, together with junctional variability and N-
region nucleotide addition enable an enormous variability within the encoded antibodies. Somatic 
mutation upon antigenic stimulation can further increase the variability. 
Antibody heavy chain 
germline gene segments 
vH 
DH 
JH 
Number of gene 
segments 
200-300 
10 
4 
Number of reading 
frames 
1 
3 
3 
Heavy-chain variation via combinatorial joining at V-D-J segments: 
250x30x12 = 
N nucleotide addition at V-D-J joints: 
Antibody light chain 
germline gene segments 
vL 
JL 
Number of gene 
segments 
100-300 
4 
Number of reading 
frames 
1 
3 
Light chain variation via combinatorial joining at V-J gene segments : 
250x12= 
Total germline encoded variation in random association of any light chain 
with any heavy chain: >90,000 x 3,000= 
Somatic hypermutation in rearranged genes during the immune response 
Number of 
possibilities 
±250 
30 
12 
90,000 
>90,000 
Number of 
possibilities 
±250 
12 
3,000 
>2.7 x 108 
>ioio 
Monoclonal antibodies 
In contrast to polyclonal antibodies, monoclonal antibodies (MAbs) are defined by their 
origin from a single B-lymphocyte. Such antibodies are obtained by in vitro fusion of 
activated B-lymphocytes with a myeloma cell line [37], The resulting hybrid cells 
(hybridomas) behave like tumor cells and undergo continuous proliferation. The antibodies 
secreted by a clone derived from a single hybridoma cell are monoclonal by definition. The 
main advantages of MAbs compared to conventional polyclonal antisera can be summarized 
as follows: 
• Animal welfare. A reduction in the number of experimental animals can be achieved. 
There is no need for renewed immunizations after a successful cell fusion. 
• Production of homogeneous and biochemically defined reagents. The standardization of 
MAb reagents will ensure that uniform results are obtained in all laboratories. In the past, 
the inherent variability of individual antisera available in only small quantities often led to 
inconsistent-results. In contrast, MAbs enjoy a constant specificity and affinity and are 
theoretically available in unlimited amounts. 
• Increased specificity. MAbs are specific for only a single epitope of the antigen and are 
therefore able to discriminate between isoenzymes and other closely related proteins [4]. 
• Selection of high affinity reagents. The screening procedure used to identify hybridoma 
clones secreting the required antibody allows the isolation of high affinity MAbs. 
Immunoassays carried out with such antibodies will be very sensitive with respect to 
antigen detection and concentration of antibody needed in the test. 
Limitations in generating MAbs 
Although, the number of MAbs directed against bacteria, fungi and nematodes is rapidly 
expanding [15,17,59,61,67], the many advantages should not obscure the fact that generation 
of MAbs against plant-pathogens is often laborious and troublesome. Upon immunization the 
immune response is triggered after recognition of foreign antigens by lymphocytes. As it is 
difficult to isolate pure plant viruses, a high percentage of the obtained hybridomas is often 
directed against the contaminating plant material that appears to be immunodominant [20]. 
For bacteria, fungi and plant-parasitic nematodes the choice of immunogen is difficult, as it is 
generally unknown which epitope is unique for a certain species. Moreover, another 
prerequisite is that this particular epitope has to be recognized by the immune system. 
In addition, the hybridoma technique of Kohler and Milstein [37] does not satisfactory 
exploit the immune repertoire. While the antibody repertoire is estimated to consist of over 
108 different antibodies (Table 1.1), only a few thousand antibodies are obtained, of which on 
average less than 1% are antigen-binding. With an optimized fusion protocol, e.g. 
electrofusion, a ten times higher fusion efficiency can be obtained [18,49], while antigenic in 
vitro stimulation or proliferation of affinity selected B-lymphocytes before fusion can yield an 
improved degree of antigen-specific hybridomas in some cases [66]. However, the problems 
of immunodominance and the enormous variability in epitopes present within the complex 
plant-pathogens also diminish the chance that a useful MAb will be obtained when these 
optimized procedures are applied. 
Another major drawback of the hybridoma technique is that it is best suited for the 
generation of murine antibodies, while the main interest has always been in human antibodies 
for medical applications, e.g. tumor therapy and tumor imaging. In these applications murine 
MAbs offer no alternative, because they can give rise to an undesired immune response in 
humans [79]. Unfortunately, considerable difficulties in making human hybridomas exist 
[10], and moreover, they cannot be directed against human tumor antigens as these are usually 
regarded as self and do not elicit an immune response. Fortunately, it was realized that the 
problems associated with generating human B-lymphocytes could be circumvented through 
immortalizing antibody genes by recombinant DNA technology, rather than by immortalizing 
the cells themselves. 
Antibody technology 
The modular nature and conserved domain structure of antibodies [33] makes them attractive 
candidates for protein engineering and since 1984, recombinant DNA technology has 
revolutionized the production of MAbs. The initial recombinant antibodies were made by 
grafting the variable domains (VL and VH) of murine hybridomas on human constant domains 
[7,47]. Later, mouse complementary determining regions, the regions responsible for antigen 
binding, were put in a human framework [32,57,73] and expression of the chimaeric antibody 
genes in mammalian cells yielded humanized antibodies. 
As yet, there are no reports of efficient expression of whole antibodies in bacteria, but 
subfragments (Fig. 1.1) such as Fabs (VHCH1 + VLCL) or Fvs (VH + VL) can be expressed 
well in Escherichia coli [5,55,63]. Spontaneous assembly of functional Fab fragments is 
observed when VHCH1 and VLCL domains are expressed as separate molecules. This 
association is in part driven by the hydrophobic interface between heavy and light chain 
residues. An interchain disulfide bond will stabilize assembled Fabs [22], but this is not a 
prerequisite for Fabs to be functional [26]. The key to expression of functional antibody 
fragments in E. coli appears to be export from the reducing environment of the cytoplasm into 
the oxidizing environment of the periplasm [56]. In contrast to Fab fragments, Fv fragments 
show a tendency to dissociate, particularly at low concentrations [21]. This can be overcome 
by connecting the C-terminus of one domain to the N-domain of the other with a flexible 
linker peptide [6,30] and expressing VH and VL domains as single-chain Fv (scFv) fusion 
proteins (Fig. 1.3). 
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Figure 1.3. The variable domains VH and VL are joined by a linker peptide (L) and single-chain Fv 
(scFv) proteins are expressed and secreted into the periplasm of Escherichia coli after induction of the 
promoter (P) with a suitable inducer. In the scFv-encoding vector, the location of the signal peptide, 
the scFv gene, an ampicillin resistance gene (AMP) and an origin of replication (E. coli ori) are 
indicated. 
Combinatorial antibody libraries of randomly assembled VH and VL genes 
Initially, expression of antibody fragments in E. coli was achieved by cloning the unique 
heavy- and light-chain encoding cDNA sequences from hybridoma cells of known specificity. 
This cloning was simplified after the introduction of the polymerase chain reaction [58] that 
allowed specific amplification of known DNA sequences. Although the nucleotide sequences 
encoding the complementary-determining regions are highly variable, the flanking regions 
have relatively conserved sequences [33]. In fact, the polymerase chain reaction provides a 
means to amplify and clone the VH and VL antibody repertoire encoding sequences directly 
from B-lymphocytes of immunized mice [38,50,60,75], thereby omitting the need for the 
generation of hybridomas. The resulting libraries were combinatorial as the amplified VH and 
VL genes were randomly recombined irrespective of their original pairing. Within biased 
combinatorial libraries (derived from activated B-lymphocytes of hyper-immunized mice) the 
number of antigen-specific V genes is high, at best < 1/500 [46] and more usually < 1/5000 
[11,54]. These libraries can therefore be relatively small (105-106) to regain original VH and 
VL pairings. 
While it is difficult and time consuming to identify MAbs produced by hybridomas, the 
ease by which E. coli can be manipulated reduces the time required for antibody production 
and characterization. Bacterial expression of diverse combinatorial antibody libraries allows 
screening of a larger population of antibody fragments (50,000 per filter) than could be tested 
previously using conventional methods [28,64]. However, this screening process was still 
very laborious, especially in view of the huge number of clones generated using combinatorial 
libraries. This difficulty in isolation of fragments with binding activity has been largely 
overcome by the development of techniques for the display of antibody fragments on the 
surface of filamentous bacteriophage. 
Mimicking the immune system by display of antibody fragments on bacteriophage 
Filamentous bacteriophage were first used to display small peptides on the minor coat 
protein pill of bacteriophage Fd, and very rare peptides could be isolated [65] through 
sequential cycles of phage growth and selection by binding to antibody. When it appeared that 
larger proteins, among which scFv-antibodies [43] or Fab fragments [25], could also be 
expressed functionally on the surface of bacteriophage (Fig. 1.4), a powerful selection system 
was created to obtain specific MAbs from combinatorial phage-antibody libraries [13]. 
Figure 1.4. Expression of a scFv-antibody fragment on bacteriophage through genetic fusion of a scFv 
gene with the gene of minor coat protein pill. In the scFv-encoding phagemid vector, the scFv gene, 
an ampicillin resistance gene (AMP), a packaging signal (Ml3 ori) and an origin of replication (E. coli 
ori) are indicated. During phage assembly the scFv-pIII encoding phagemid is packaged into the phage 
particle and the scFv-pIII fusion protein is expressed on the phage surface. Consequently, the 
phenotype and genotype are linked. 
In the immune system the B-lymphocytes represent self-replicating packages. They contain 
the antibody genes that encode the antibody displayed at their surface. Filamentous 
bacteriophage expressing functional antibody fragments on their surface, thus, mimic the B-
lymphocyte by linking genotype and phenotype. 
The phage display system (Fig. 1.5) allows direct selection of antibodies with rare 
specificities from combinatorial phage display antibody libraries through successive rounds of 
phage growth and selection for antigen binding. For instance, Bradbury and co-workers [8] 
showed the feasibility of this technique by selecting antigen binding phages from a pool of 
non-binding phages, even at a ratio of one binding in 109 irrelevant phages. 
Presently a variety of formats for antibody phage display exist. Antibody fragments can 
be cloned directly into the genomes of filamentous bacteriophage or, alternatively, phagemid 
vectors can be used. These plasmid-based vectors have sequences derived from the intergenic 
regions of filamentous phage, which enable them to replicate as a single stranded DNA in E. 
coli. These phagemids are packaged into filamentous phage particles (rescued) when cells 
harboring them are co-infected with helper phage such as M13K07 [74], that provide all the 
phage proteins but due to a defective origin they are themselves poorly packaged in 
competition with the phagemids. 
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Figure 1.5. Schematic representation of the selection of antigen-specific single-chain antibody 
fragments (scFvs) from a combinatorial antibody library using phage display. Helper phage, which 
contain the entire phage genome but lack an efficient packaging signal, are used to 'rescue' phagemids 
from a combinatorial library. When both helper phage and phagemid are present within the same 
bacterium, phage-antibodies (PhAbs) are assembled that carry fusion proteins of scFv and minor coat 
protein pill on their surface and contain the scFv-encoding phagemid vector. In order to select for 
antigen specificity, PhAbs rescued from a combinatorial antibody library are allowed to bind to 
immobilized antigen (Panning). Washing removes the PhAbs that lack affinity for the antigen. Bound 
PhAbs are eluted, and the selected PhAbs are enriched by sequential rounds of panning until the 
desired affinity is obtained. 
The number of antibodies, displayed on each phage particle, can be varied to a great extend. 
Antibody fragments can be genetically fused to the gene encoding the minor coat protein pill 
(3-5 copies per particle), and be displayed at 3 (possibly 5) copies per bacteriophage 
[1,19,25,43]. The major coat protein pVIII (2700 copies per particle) can also be used to 
display antibodies on phage [12,25,29,34], but these phages are not viable unless wild-type 
pVIII coat protein is provided by helper phage. The use of the phagemid/helper phage system 
leads, through competition for wild-type coat proteins to fewer copies of the antibody fusion 
being displayed. With helper phage providing wild-type pVIII and pill coat proteins, 
approximately 24 antibody fragments are incorporated per phage if antibody-pVIII encoding 
phagemids are used [34], whereas less than one antibody is incorporated per phage for 
antibody-pill fusions. Because avidity effects are avoided, fusions to pill coat proteins have 
to date been preferred over pVIII for antibody display and were used to select high affinity 
antibodies from combinatorial antibody phage display libraries using a wide variety of 
selection strategies. 
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Figure 1.6. Antibody production in vivo and in vitro and the type of combinatorial library that can be 
constructed using the PCR amplified V genes derived from stem cells, B-lymphocytes or plasma cells 
(activated B-lymphocytes). 
Bypassing immunization 
The major disadvantage of biased combinatorial antibody libraries, assembled from B-
lymphocytes of immunized sources, is that for each antigen a new library has to be 
constructed. Moreover, immunization of humans for this purpose is not ethical and self-
antigens are not suited to elicit an immune response. However, it is possible to bypass 
immunization and to construct naive combinatorial phage display antibody libraries using V 
genes of non-immunized sources (Fig. 1.6). The probability of isolating high affinity 
10 
antibodies towards every imaginary antigen from such a repertoire is dependent on the 
diversity of the library [53]. Therefore, these naive antibody phage display libraries have to be 
as large as possible. Naive human combinatorial antibody phage display libraries have been 
constructed that are comparable to the natural immune repertoire with a diversity of 
approximately 108 scFv-antibodies [41] or even more diverse, with 1010 scFv-antibodies [72]. 
Using an in vivo recombination technique, which applied the Cre-enzyme of phage PI [76], 
construction of a naive combinatorial Fab phage display library with a diversity of 1012 was 
achieved [23]. 
Alternatives for the use of rearranged V repertoires from a non-immunized source are 
cloned human germline VH and VL sequences. Using these genes, amplified with a specific 5' 
end and a synthetic CDR3 primer (Fig. -1.6), large (>108) synthetic combinatorial antibody 
libraries [2,26,48] were constructed. In addition, a synthetic Fab phage display library (108) 
was constructed in which the natural structure of the CDR3 was retained [16]. 
Selection of specific antibodies from combinatorial antibody phage display libraries 
Naive and synthetic combinatorial antibody phage display libraries encode antibodies of 
considerable diversity and can theoretically be used to select antibodies against many 
different antigens. In addition, the phage display system may also prove to be a more 
universal method to obtain specific MAbs, since the antibody specificity is not biased towards 
immunodominant epitopes as immunization procedures are omitted. Phages, encoding 
displayed antibody fragments, can be affinity selected from combinatorial antibody phage 
display libraries for binding to a particular antigen by passing the phage-antibodies over 
immobilized antigen (panning). Several formats have been used, such as immobilized antigen 
on a column matrix [43], antigen-coated plastic tubes or dishes [41], biotinylated antigen in 
solution followed by capture on streptavidin coated beads [24] and whole cells [16,42]. 
Phages that are bound to antigen are retained on the surface. Non-binding phage-
antibodies are removed by washing. Bound phage-antibodies can be eluted by aspecific 
elution using acid [1] or alkaline buffers [40] or more specifically using competition with 
soluble antigen [13], proteolysis of spacers located between phage and antibody or reduction 
of disulfide bonds in biotinylated antigens. The selected (eluted) phages are used to infect E. 
coli and can be applied in several sequential rounds of phage growth and selection, allowing 
even rare phage-antibodies to be isolated. 
Screening of the selected antibodies 
The success of the panning against an antigen can be assessed, using a phage-ELISA for 
screening the specificity of the selected phage-antibodies (Fig. 1.7). Alternatively, one of the 
more useful features in phage display vectors, the presence of an amber stop-codon at the 
junction between the antibody and the coat protein, can be used for facile switching between 
fused and soluble antibodies (Fig. 1.7). Because most recombinant antibodies have a peptide 
tag fused to the C-terminus, the reaction towards antigen can also be determined in ELISA. 
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Figure 1.7. The application of an amber codon allows facile switching from production of phage-
antibodies to soluble scFvs by changing the non-suppressor strain (wherein translation proceeds at the 
amber codon) to a suppressor strain (wherein translation halts at the amber-codon). In the scFv-
encoding vector the location of a ribosomal binding site (RBS), a signal peptide (Sp), a scFv, a His(6)-
tag, a cmyc-tag, an amber codon and the pill gene are indicated. The produced phage-antibodies can 
be applied in phage-ELISA (lower left) and the soluble scFvs in cmyc-ELISA (lower right). Bound 
phage-antibodies or scFv antibodies can be detected with alkaline phosphatase (AP) labeled anti-phage 
antibodies or anti-cmyc antibodies, respectively. Visualization of the reaction can be achieved by 
addition of a colorless substrate that is modified into a colored compound by AP. 
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Objective of this thesis 
Many MAbs against a broad variety of antigens have been isolated from naive and synthetic 
combinatorial antibody libraries with the aid of the phage display technique [23,48,72]. 
Therefore, it appears that this technique offers features that can not be achieved using the 
hybridoma technique, i.e. high variability in the antibody repertoire and, as no laboratory 
animals are required for immunization purposes, there is no bias towards immunodominant 
epitopes. Moreover, production of recombinant antibodies in bacteria is fast and relatively 
cheap. Based on these features, the phage display technique might be well equipped to select 
plant-pathogen specific MAbs from combinatorial antibody libraries. 
The objective of this thesis is to show that the phage display technique is indeed 
applicable for selection of specific recombinant MAbs that can be used in reliable and 
sensitive immunoassays for the detection of pathogens in or on plant material. Therefore, the 
phage display technique was used to select recombinant scFv-antibodies against several plant-
pathogens of which it is known that specific hybridoma derived MAbs can be selected only 
with great difficulty. 
In the second chapter we describe the selection of Ralstonia solanacearum-specific 
MAbs from a naive combinatorial scFv library with the aid of the phage display technique. 
The selected scFv-antibodies were screened for their specificity for R. solanacearum by 
testing them against several closely related as well as a panel of saprophytic bacteria. 
In Chapter 3 is described that several beet necrotic yellow vein virus-specific monoclonal 
scFv-antibodies were selected from a synthetic combinatorial scFv library. Initially, these 
scFv-antibodies reacted only when they were displayed on phage, but not when they were 
expressed as soluble protein. An improvement in expression was achieved by expression of 
the scFvs as fusion protein with alkaline phophatase. 
It was realized that the inability to express scFvs as soluble proteins was a general 
problem. Chapter 4 describes the optimization of expression and screening procedures, 
starting with the observation (Chapter 3) that several of the selected scFv could be expressed 
as scFv-alkaline phosphatase fusion protein but not as soluble scFvs. 
In the fifth chapter, the optimized screening and expression procedures are applied to 
select the recombinant antibodies directed against tomato spotted wilt virus. This finally 
resulted in the development of a sensitive ELISA that is fully based on recombinant 
antibodies. 
In Chapter 6, it is shown that besides genetic fusion of scFv-antibodies to enzymes like 
alkaline phosphatase, fluorescent proteins can also be used as a versatile fusion partner. The 
obtained fluorescent antibodies (fluobodies) can be directly used in immunofluorescent cell 
staining and flow cytometry. 
In the summary and concluding remarks section (Chapter 7), the use of the phage display 
system and naive combinatorial antibody libraries is discussed for the selection of MAbs 
against plant-pathogens. Recent data, obtained from testing laboratories, will be used to show 
that several of the selected recombinant antibodies can be used in routine diagnosis. 
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Chapter 2 
Development of specific recombinant monoclonal antibodies 
against the lipopolysaccharide of Ralstonia solanacearum race 3 
ABSTRACT 
Recombinant single-chain antibodies (scFvs) against the lipopolysaccharide of Ralstonia 
solanacearum (biovar 2, race 3) were successfully selected by phage display from a large 
combinatorial antibody library. Characterization with regard to cross-reaction and use in 
routine immunoassays showed that the selected antibodies had improved characteristics when 
compared to the polyclonal antiserum which is currently used for 'brown rot' diagnosis of 
potato in the Netherlands. The isolated monoclonal scFv antibodies reacted both in ELISA 
and in immunofluorescence cell staining with all race 3 strains tested but only with some 
strains belonging to other races. Furthermore, only a few cross-reactions with saprophytic 
bacteria that cross-reacted with polyclonal antisera were observed. One of the recombinant 
antibodies detected as few as 5 x 103 bacteria in potato tuber extracts in ELISA. Therefore, 
this antibody is potentially useful for detection off. solanacearum race 3. 
This chapter has been published in a modified form as: Griep, R.A., Van Twisk, C, Van Beckhoven, 
J.R.C.M., Van der Wolf, J.M. and Schots, A. (1998) Development of specific recombinant monoclonal 
antibodies against the lipopolysaccharide of Ralstonia solanacearum race 3. Phytopathology 88 (8): 
795-803. 
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INTRODUCTION 
Ralstonia solanacearum is the causal organism of bacterial wilt and can infect over 450 
different plant species, including many economically important crops [7]. The genus R. 
solanacearum (formerly Pseudomonas solanacearum) can be classified into 3 races 
(designated according to host range specificity) or grouped into 5 biovars on the basis of 
utilization of disaccharides and hexose alcohols. Race 3, nearly synonymous with biovar 2, 
forms a homogeneous group [26] and its host range is restricted to potato, eggplant and 
tomato. Race 3 is more adapted to temperate regions and is responsible for recent outbreaks of 
potato brown rot disease in different countries in Europe [27]. 
Quarantine measures have been taken in many countries to minimize the risk of 
introduction and spreading of the potato brown rot pathogen. Serological techniques, such as 
ELISA, immunofluorescence cell-staining (IF) and immunofluorescence colony staining 
(IFC), are commonly used to monitor the presence of the pathogen in potatoes and in the 
environment. In general, they are considered to be a good compromise between sensitivity and 
specificity of detection, and ease and expense of application [5, 22, 25]. 
So far, only polyclonal antibodies (PAbs) against whole or glutaraldehyde-fixed cells of R. 
solanacearum race 3 have been used in certification and risk assessment programs [5, 11]. 
However, the occurrence of false-positive reactions due to the presence of cross-reacting 
saprophytic bacteria in the extracts is considered a serious drawback to the use of PAbs. In IF 
cell staining, up to 3% false-positive reactions were recorded [11] while in ELISA the 
frequency of false-positive reactions can sometimes exceed this level (Elphinstone, personal 
communication). Consequently, positive reactions need to be followed by confirmation 
assays, for which often tedious and time-consuming bioassays have to be used. 
In contrast to PAbs, hybridoma-derived monoclonal antibodies (MAbs) recognize only one 
epitope and thus a higher level of specificity is feasible. Attempts to produce MAbs against R. 
solanacearum were successful [1, 2, 8, 22]. However, the derived MAbs were not applicable 
for brown rot diagnosis in potatoes. The species-specific IgM MAb Psl, raised by Alvarez et 
al [1,2], reacted with extracellular polysaccharide-I in a very sensitive immunoassay [17] but 
failed to react with afluidal mutants [2] which can still be pathogenic [31], despite the 
phenotype conversion. Moreover, MAb Psl is not applicable for IFC in agarose plates for its 
large molecular mass of 900 kDa reduces gel diffusion and slows down staining and washing 
procedures. The MAbs developed by He [8], reacted with race 1 and 2, but not with race 3 
strains [8]. Strain-specific MAbs that do not cross-react with the most closely related species 
(R. picketti, R. syzygii, Burkholderia cepacia or the banana blood disease bacterium) were 
developed successfully by Robinson et al [22]. However, these MAbs were not useful for 
certification of potato propagation material, as they did not react with 11 of 23 R. 
solanacearum strains tested, including two race 3 strains. In addition, they did not react in IF-
techniques and a 100-fold decrease in sensitivity was observed in ELISA when PAbs were 
replaced by MAbs. 
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The difficulties mentioned above, in developing a R. solanacearum race 3 specific MAb 
which is suited for potato brown rot diagnosis using ELISA, IF and IFC techniques, might be 
caused by inefficient exploitation of the immune repertoire in the hybridoma technique. After 
all, whereas the available (mouse) antibody repertoire is estimated to include over 108 
different antibodies, only a few thousand different hybridoma clones are obtained, of which on 
average less than 1% produce antigen binding antibodies. Thus, the probability of selecting 
MAbs of sufficient specificity and affinity for use in a diagnostic assay is low. 
These diversity and efficiency problems were solved by recent advances in molecular 
immunology (Chapter 1). Forced cloning of antibody variable heavy (VH) and light (VL) chain 
genes by RT-PCR [20, 24] allowed amplification of the DNA encoding the antibody 
repertoire. Coupling VH and VL domains with a flexible peptide linker [10] enabled 
expression of variable antibody fragments (Fv) in Escherichia coli as single-chain Fv (scFv) 
molecules. Cloning of a pool of scFv encoding genes, in which the VH and VL domains were 
randomly combined, allowed the generation of large combinatorial antibody libraries. Today 
combinatorial libraries of over 1010 different antibodies have been constructed [6, 30]. This, in 
combination with the display of functional antigen binding fragments on the tips of 
filamentous phage created a powerful system to select specific MAbs [6,9,16,30] without the 
need for immunization i.e. without the use of experimental animals. 
In this study, the versatility of the phage display system was challenged for the selection of 
R. solanacearum specific MAbs. To achieve this, phages derived from a large naive human 
combinatorial antibody library [30] were panned against purified lipopolysaccharides (LPS) of 
R. solanacearum and the expressed scFv-antibodies were characterized by ELISA and IF. 
MATERIALS AND METHODS 
Bacterial strains and growth conditions 
E. coli strains used for the isolation of recombinant antibodies, were TGI (K12, A(lac-pro), 
supE, thi, hsdDS/F' traD36, proA+B+, lacf, /acZAM15) for selection of specific phage-
antibodies and HB2151 (K12, ara, Mac-pro), thi/F'/proA+B+, lacPZAMIS) for production of 
soluble scFv-antibody fragments. 
Strains of R. solanacearum and strains of cross-reacting bacteria were preserved at -80°C 
on beads (Protect Bacterial Preservers, Biotrading Benelux, Wilnis, NL) in 15% glycerine, 8 
mg/ml LabLemco broth (Oxoid, CM15). For each experiment, bacteria were grown for 48 to 
72 h at 27°C on plates of Trypticase Soy Broth (30 g/1; BBL), and prior to use transferred to 
slopes of growth factor agar (2.3 mM K2HP04, 0.2 mM MgS04.7H20, 1.7 mM NaCl, 4.3 mM 
NH4H2P04, 5 mM glucose, 0.5% (w/v) yeast and 1.5 % (w/v) agar, pH 7.2) and grown for 24 
h at 27°C. Characterization of cross-reacting bacteria by fatty acid analysis, using the 
Microbial Identification System (Microbial ID, Newark, Delaware, USA), was kindly done by 
Dr. J.G. Elphinstone [Central Science Laboratory (CSL), York, UK]. 
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Purification of lipopolysaccharides 
The purification of lipopolysaccharides (LPS) from R. solanacearum (strain 1609: race 3, 
biovar 2) was performed according to De Weger et al [4]. 
Panning procedure 
Selection of phage-antibodies (phages expressing functional scFvs on their surface) from the 
human combinatorial antibody library was performed according to Vaughan et al [30] with a 
few modifications. Immunosorbent tubes (Maxi-sorb, Nunc) were coated with 500 ug LPS 
(125 ug/ml in 50 mM NaHC03, pH 9.8) for 18 h at 4°C. The tubes were washed twice with 
PBS and blocked with PBM-2% (PBS containing 2% skimmed milk powder) for 30 min at 
room temperature. Simultaneously, 2 ml of a stock derived from the Vaughan library [30], 
containing 2.5 x 1013 phages displaying scFv antibodies (PhAbs), was mixed with 2 ml of 
PBM-4% and preincubated for 30 min. After removing the blocking solution from the tubes 
and washing with PBS, 4 ml of PhAbs was added to the tubes. PhAbs were allowed to bind to 
LPS for 30 min on a roller bench and for another 90 min without rotation. Free PhAbs were 
removed by washing the tubes 10 times with PBS containing 0.1% Tween-20 and for another 
10 times with PBS to remove the detergent. Bound PhAbs were eluted by adding 1 ml 0.1 M 
triethylamine (TEA) and subsequent incubation for 10 min on a roller bench. After collecting 
the TEA eluent, the pH was neutralized by addition of 0.5 ml 1 M Tris/HCl pH 7.4. One ml of 
the eluted PhAbs was used to infect 5 ml of E. coli TGI bacteria (or HB2151 in the final 
panning round), which were freshly grown to an OD^o of 0.5 in 2 x tryptone yeast broth 
(2TY, [23]). After infection (30 min, water bath at 37°C without shaking to allow optimal 
infection), the E. coli cells were pelleted (3,000 x g, 10 min) and subsequently resuspended in 
1 ml of 2TY broth containing 100 ug/ml ampicillin and 2% glucose (2TYB-AMP-2%Glu). To 
establish the number of eluted PhAbs, 50 (al was taken from this suspension and serial 
dilutions were plated on 2TY agar plates containing 100 ug/ml ampicillin and 2% glucose 
(2TYA-AMP-2%Glu). The remaining 950 ul was plated separately on 225 X 225 mm 2TYA-
AMP-2%Glu plates, and the bacteria were grown for 18 h at 30°C. 
This procedure was carried out four times in succession, using PhAbs prepared as 
described below for the second, third and fourth panning round. To increase the specificity 
and to reduce the background the stringency was increased after the second panning round. 
The amount of antigen that was used for coating was then decreased from 125 ug/ml to 10 
ug/ml in the third and to 1 ug/ml in the final panning round. Simultaneously, the stringency 
was further enhanced by increasing the number of washings from 20 times after the second 
panning round to 40 times in the subsequent rounds of selection. 
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Preparation of phage-antibodies for subsequent panning rounds 
The bacteria, derived from a previous panning round, were scraped from the plate (225 x 225 
mm) and resuspended in 15 ml of 2TYB-AMP-2%Glu. From these bacteria 14.5 ml was used 
to prepare a freezer stock [22] and 500 ul was used to inoculate 50 ml of 2TYB-AMP-l%Glu 
and the bacteria were grown at 37°C with shaking (250 rpm). When an OD60o of 0.5 was 
reached, 1011 helper phages (M13K07, Pharmacia, Uppsala, Sweden) were added (multiplicity 
of infection 20). The 15 ml tube containing the mixture was put in a water bath at 37°C, 
without shaking to allow for optimal infection. After 30 min the bacteria were pelleted (2,100 
x g, 10 min) and resuspended in 25 ml 2TYB-AMP and 25 ug/ml kanamycin. The bacteria 
were transferred to a 250 ml Erlenmeyer flask, and grown for 18 h at 30°C with shaking (250 
rpm). The 25 ml overnight culture was harvested and the bacteria were removed by 
centrifugation (2,100 x g, 20 min). The PhAbs in the supernatant were precipitated by adding 
5 ml of 20 % PEG-6000, 2.5 M NaCl and thoroughly mixed for 1 h at 4°C. The precipitated 
PhAbs were pelleted (2,100 g, 20 min) and resuspended in 1 ml of sterile PBS. Usually 5 x 
1012 PhAbs/ml were produced, as assayed by infection of strain TGI and plating for ampicillin 
resistance. The derived PhAbs were stored at 4°C until use in the next panning round or in 
phage-ELISA. 
Mval-fingerprinting 
To analyze the diversity of the selected PhAbs, restriction fragment length polymorphism 
(RFLP) fingerprinting was performed on PCR amplified scFv DNA. Single colonies were 
picked and grown for 4 h in 2TYB-Amp-2%Glu. From these suspensions, 2 ul was taken and 
added to a 48 ul PCR mix containing 2.5 uM dNTPs; 0.25 U Super Taq DNA polymerase 
(HT Biotechnology, Cambridge, UK); 10 uM forward (5'-AGG AAA CAG CTA TGA CCA 
TGA TTA CGC CAA G-3') and 10 uM reverse (5'-GCC CAA TAG GAA CCC ATG TAC 
CGT AAC ACT G-3') primers; 2 mM MgCl2 and 50 mMTris/HCl, pH 8. In a thermal cycler 
(Perkin Elmer), 25 cycles (1 min 94°C; 2 min 72°C) were performed. From the PCR mix, 20 
ul was added to 37.5 ul H20 and 6.5 ul of buffer H (Boehringer, Mannheim, Germany). After 
mixing, 10 U Mval (Boehringer) was added and the mixture was incubated for 18 h at 37 °C. 
The Mval digestion patterns were analyzed on a 3% FMC Metaphor agarose gel (Epicentre 
Technologies, Madison, USA). 
Production and Purification of scFvs 
HB2151 bacteria were cultured according to Kerschbaumer et al [12] and pelleted. After 
incubation (5 min, 0°C) of the bacteria with 1/20 volume (referring to the original culture 
size) 50 mM Tris/HCl, pH 8 buffer containing 30% sucrose and 1 mM EDTA, the scFvs were 
extracted (45 min, 0°C) from the periplasm with 1/20 volume (referring to the original culture 
size) of 5 mM MgS04. Secreted scFvs were purified from the periplasmic fraction using 
immobilized metal affinity chromatography (IMAC) according to Lindner et al [15]. 
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Routine protocol for the extraction of potato tubers 
The extraction of potatoes was carried out according to the legislation of the European 
Community (97/647/EG). Briefly, maceration buffer (4.26 g Na2HP04 en 2.72 g KH2P04 (50 
mM PO4) per liter of distilled water, pH 7.0) was added till 200 heel ends were fully 
submerged. The sample was incubated during 18 h at 6°C while shaking (75 rpm) and filtrated 
through a 40 to 100 um filter. Filtrate was collected after washing the filter with maceration 
buffer and centrifuged during 15 min at 10,000 g at 6°C. The pellet was resuspended in 1 ml 
of 10 mM phosphate buffer (2.7 g/1 of Na2HP04.12H20 and 0.4 g/1 of NaH2P04.2H20, pH 
7.2). Glycerin was added to a final concentration of 15% and samples were stored at -70°C. 
ELISA 
A phage-ELISA was used to assess the specificity of the phage-antibodies which were derived 
from the for panning rounds, according to standard methods [3, 28], in which the plates were 
washed four times with PBST (PBS containing 0.1% Tween-20) between each incubation 
step. Briefly, a 96-well microtiter plate was coated with LPS (2 ug/ml in 0.1 M NaCOs), for 2 
h at 37°C at 100 ul/well. After blocking with PBSTM-5% (PBS containing 0.1% Tween-20 
and 5% skimmed milk powder) at 200 ul/well, the plates were incubated for 1 h with PhAbs 
in PBSTM-1% at 100 ul/well. After that, the plates were incubated at 100 ul/well with anti-
M13 monoclonal antibodies (MAb 12E4, diluted to 5 ug/ml in PBSTM-1%) and finally with 
rat anti-mouse PAbs conjugated to alkaline phophatase (RaAM-AP, Jackson Immuno 
Research Laboratories Inc., Westgrove, PA), diluted 1:2,000 in PBSTM-1%. The reaction 
with LPS was visualized by incubation with p-nitrophenyl phosphate substrate (p-NPP). 
An indirect ELISA was used to assess the specificity of the recombinant scFv-antibodies, 
according to standard methods [3, 28], in which the plates were washed three times with 
PBST (PBS containing 0.1% Tween-20) between each incubation step. Briefly, a 96-well 
microtiter plate was coated, either with LPS (2 ug/ml in 0.1 M NaC03) or with bacteria 
(OD60o of 0.1 in 0.1 M NaC03), for 2 h at 37°C at 100 ul/well. After blocking with PBSTM-
5% at 200 ul/well, the plates were incubated for 1 h with PAbs PcA-9523 (a polyclonal 
antiserum which was produced against whole cells of R. solanacearum race 3 strain 1609, 
diluted 1:2000 in PBSTM-1%; PAb-ELISA) or with scFvs (cMyc-ELISA) diluted in PBSTM-
1% at 100 ul/well. After that, the plates were incubated at 100 ul/well, with goat anti-rabbit 
PAbs conjugated to alkaline phosphatase (GaR-AP, Sigma, 1:2,000; PAb-ELISA) or anti-
cMyc monoclonal antibodies (MAb 9E10 [18], diluted to 1 ug/ ml in PBSTM-1%; cMyc-
ELISA [9] and finally with RaAM-AP (Jackson), diluted 1:2,000 in PBSTM-1%. The reaction 
with LPS was visualized by incubation with p-NPP. 
The detection limits of the scFv-antibodies and polyclonal antiserum PcA-9523 for R. 
solanacearum were determined with an indirect double antibody sandwich ELISA, in which 
the plates were washed three times with PBST between each subsequent incubation step. 
Briefly, ELISA plates (Greiner, intermediate binding capacity: cat. no. 655001) were coated 
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with PAbs PcA-9523 (diluted 1:2,000 in 0.1 M NaC03) at 100 ul/well for 2 h at 37°C. After 
blocking with PBSTM-5% for 30 min at 200 |il/well, the plates were incubated with ten-fold 
serial dilutions of R. solanacearum bacteria (diluted in either PBS or in potato tuber extract) at 
100 ul/well for 2 h at 37°C. Subsequently, the plates were incubated with either PcA-9523-AP 
conjugate (diluted 1:2,000 in PBM) or with scFv anti-LPS 12 (diluted to 5 ug/ml in PBM-2%) 
at 100 ul/well for 1 h at 37°C. This was followed by subsequent incubations with anti-cMyc 
MAb 9E10 (1 jig/ml in PBM-2%) and RaAM-AP (1:2,000 in PBM-2%) at 100 ul/well for 1 
h. The reactions were visualized by incubation with either p-NPP substrate or with 
fluoresceindihosphate (FDP) substrate. Optical densities at 405 nm were measured with an 
Anthos ELISA-reader and fluorescence was measured at 510 nm with a fluorometer (Perkin 
Elmer, 7700). 
Western blotting 
Purified LPS (0.5 ug/lane) was separated by SDS-PAGE and transferred to nitrocellulose 
membranes as described by Van der Wolf et al [29]. Reactive groups on the membrane were 
blocked with PBMT-5%. The reactivity of the scFv towards LPS was shown by subsequent 
incubations of the blot with anti-LPS scFv, anti-cMyc MAb 9E10 (10 ug/ml in PBM-2%), 
RaAM-AP (1:2,000 in PBM-2%) and BCEP substrate. 
Immunofluorescence cell staining 
IF was performed according to Van der Wolf et al [29]. For IF cell-staining the bacteria were 
coated on microscope slides and subsequently incubated with anti-LPS scFv (12,5 to 125 
ug/ml PBS) and anti-cMyc MAb 9E10 (30 ug/ml PBS), which was conjugated with 
fluorescein isothiocyanate (FITC). 
RESULTS 
Selection of LPS binding clones from a combinatorial antibody library 
From the first panning round in which 2.5 x 1013 PhAbs (expressing 1.4 x 1010 different 
scFvs) were applied to the LPS coated immunosorbent tube, approximately 1.5 x 106 PhAbs 
were recovered (Fig. 2.1 A). In the subsequent rounds of selection, enrichment factors of 100 
to 1000-fold were obtained, as the stringency during the selection was gradually increased. 
Increasing signals in phage-ELISA (Fig. 2. IB) paralleled the increased efficiencies of 
recovery during panning. This result indicates that phages binding to LPS were enriched 
during the selection procedure. 
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Figure 2.1. Recovery and specificity of LPS-binding phage-antibodies in 4 sequential rounds of 
panning. PhAbs were applied to LPS coated tubes and allowed to bind. Bound PhAbs were eluted after 
washing and used to infect E. coli. After phage rescue, with helper phage, the PhAbs (anti-LPS 
enriched) were used for a new round of panning. The number of applied and recovered PhAbs was 
counted and the recovery was plotted for each subsequent panning round (A). A phage-ELISA was 
done (B) with equal amounts of the selected anti-LPS PhAbs and compared to comparable amounts of 
control PhAbs (derived from a panning against another antigen) to show that the binding was LPS 
specific. 
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Figure 2.2. Characterization of four anti-LPS clones by Mval-RFLP finger printing of the scFv 
encoding DNA: lane 1, anti-LPS 3; lane 2, anti-LPS 8; lane 3, anti-LPS 12 and anti-LPS 13, lane 4. 
Characterization of monoclonal LPS-binding scFv 
Four bacterial clones, which produced scFvs with high activity in the cMyc-ELISA 
(designated anti-LPS 3, anti-LPS 8, anti-LPS 12 and anti-LPS 13), were further characterized. 
The variability within the scFv genes was established using RFLP of PCR amplified DNA. 
Four different Mval-restriction patterns were observed (Fig. 2.2). Although the patterns of 
anti-LPS 12 and anti-LPS 13 looked quite similar, nucleotide DNA sequencing of plasmid 
DNA revealed that these scFvs were different (data not shown). The four different scFvs were 
purified by immobilized metal affinity chromatography. Anti-LPS 3 could only be purified in 
low amounts, 50 u,g/l maximum yieldscore, and SDS-PAGE indicated that the bulk of this 
was degraded, as it did not have the expected molecular mass of 27 kDa (data not shown). 
This was in contrast to the scFvs anti-LPS 8, 12 and 13 that yielded up to 1.5, 3 and 2.5 mg of 
intact scFv-antibody per liter, respectively. 
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Purified scFvs anti-LPS 8, 12 and 13 gave high signals when tested in cMyc-ELISA with 
purified LPS (Fig. 2.3) and with R. solanacearum cells (data not shown), whereas a weak 
reaction was found with scFv anti-LPS 3. Similar results were obtained with IF. The scFvs 
anti-LPS 8, 12 and 13 but not scFv 3 gave bright fluorescent staining of R. solanacearum at 
12.5 |ig/ml (Fig. 2.4A) and brilliant fluorescence at 125 ug/ml (data not shown). It was 
confirmed that the scFvs indeed reacted with LPS of R. solanacearum by Western blotting, 
whereas no reaction with LPS from R. picketti was found (Fig. 2.4B). 
Figure 2.3. Reaction of purified monoclonal scFv 
antibodies (anti-LPS 3, anti-LPS 8, anti-LPS 12 
and anti-LPS 13) with LPS in ELISA. ELISA 
plates were coated with LPS derived from R. 
solanacearum. ScFv antibodies were applied and 
the binding to LPS was detected by subsequent 
incubations with anti-cMyc MAbs, Rat anti-Mouse 
PAbs conjugated with alkaline phosphatase and 
para-nitrophenylphosphate. 
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Figure 2.4. Immunofluorescence staining of whole R. solanacearum bacteria (A), showing that a 
surface epitope is recognized by scFv anti-LPS 12 (12.5 ug/ml) and a Western blot (B), showing that the 
epitope which is recognized is located on the LPS of R. solanacearum. Purified LPS, derived from R. 
solancearum (tracks 1 and 3) and R. picketti (tracks 2 and 4) was blotted onto nitrocellulose and stained 
with silver (tracks 1 and 2) or with scFv anti-LPS 12 (tracks 3 and 4), respectively. 
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The detection limit for R. solanacearum of scFv anti-LPS 12, the most reactive of the 
isolated scFvs, was comparable to polyclonal antiserum PcA-9523. In a double antibody 
sandwich ELISA, both could detect as few as 4 x 104 cells ml"1 when in pure culture (Table 
2.1). No difference in sensitivity was observed between the chromatogenic substrate p-NPP 
and the fluorogenic substrate FDP. The signals obtained were higher for PcA-9523 than for 
scFv anti-LPS 12, but the background value of scFv anti-LPS 12 was lower, especially when 
FDP substrate was used instead of p-NPP. 
For evaluation of scFv anti-LPS 12 for routine application, R. solanacearum cells were 
also diluted in a potato tuber extract and compared to serial dilutions of a pure culture. The 
lowest concentration of R. solanacearum cells that could be detected in the sandwich ELISA 
with scFv anti-LPS 12 was 5 x 103 cells ml"1 in the potato tuber extract (Table 2.2). Even 
though high numbers of saprophytic bacteria were present in the tuber extract, only slightly 
reduced signals were obtained and the sensitivity was comparable to the pure culture. 
Table 2.1. Comparison of scFv anti-LPS 12 and polyclonal antiserum PcA 9523 for their detection 
limits for R. solanacearum race 3 in ELISA. Bacteria, strain 1609, were suspended in PBS and applied 
in different concentrations. The reactions were visualized using the chromatogenic substrate p-NPP or 
the fluorogenic substrate fluoresceindiphosphate (FDP). 
R. solanacearum 
concentration 
(cfu/ml) 
4xl05 
4xl04 
4xl03 
4xl02 
0 
p-NPP 
scFv 12a 
2.8d 
0.86 
0.21 
0.15 
0.16 
ELISA substrates 
(OD4Qg value) 
PcA-9523b 
2.9 
0.9 
0.42 
0.35 
0.20 
FDP (relative 
scFv 12c 
3.3 
0.7 
0.14 
0.10 
0.09 
fluorescence) 
PcA-9532c 
2.9 
2.5 
0.83 
0.69 
0.68 
a.b.cjucubauon times with substrate were 120, 40 or 80 minutes, respectively. 
dThe data were obtained from a representative experiment and the standard deviations (n=2) were 
smaller than 0.1 for all presented data. ELISA signals which exceeded at least three times the 
background value were regarded as a positive response. 
Table 2.2. Values obtained in an ELISA, with scFv anti-LPS 12 against R. solanacearum race 3, using 
the chromatogenic substrate p-NPP or the fluorogenic substrate fluoresceindiphosphate (FDP). 
Different concentrations of R. solanacearum bacteria, strain 1609, were suspended in PBS (pure 
culture) or in a potato tuber extract and the detection limits were assayed with a double antibody 
sandwich ELISA. 
R. solanacearum 
concentration 
(cfu/ml) 
5xl05 
5xl04 
5xl03 
5xl02 
0 
p-NPP 
pure culture 
>3b 
1.4 
0.44 
0.33 
0.28 
ELISA substrates (units) 
(OD405)a 
tuber extract 
>3 
1.1 
0.44 
0.36 
0.31 
FDP (relative fluorescence)3 
pure culture 
3.1 
1.9 
0.51 
0.19 
0.11 
tuber extract 
2 
1.6 
0.31 
0.18 
0.1 
aIncubation time with substrate was 120 minutes. 
^The presented data describe a typical experiment and the standard deviations (n=2) were smaller 
thanO.l. ELISA signals which exceeded at least three times the background value were regarded as a 
positive response. 
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Testing of the scFvs against several R. solanacearum strains, both in ELISA and IF (Table 
2.3), revealed that they reacted with all strains of race 3, but only with some of the race 1 
strains. No difference was observed between the specificities of the anti-LPS 8, anti-LPS 12 
and anti-LPS 13 scFv antibodies, and therefore only the results with scFv anti-LPS 12 are 
shown. 
Table 2.3. Comparison of the reactivity of monoclonal scFv (anti-LPS 12) and polyclonal antiserum 
(PcA 9523) with R. solanacearum in ELISA and IF. 
Strain 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum 
R. solanacearum! 
R. solanacearum 
R. solanacearum 
Isolated in 
Country 
Brazil 
Costa Rica 
Panama 
France 
France 
Indonesia 
Hawaii 
Japan 
Panama 
Costa Rica 
Egypt 
Netherlands 
Netherlands 
Netherlands 
Egypt 
India 
France 
Chile 
Netherlands 
Netherlands 
Netherlands 
United 
Kingdom 
United 
Kingdom 
Unknown 
France 
France 
IPO 
number 
1657 
1653 
1655 
1656 
1669 
1670 
1654 
1658 
1665 
1666 
933 
1608 
1609 
1610 
1661 
1662 
1663 
1664 
1676 
1677 
1678 
1681 
1684 
1652 
1711 
1712 
Original 
number 
PD1414 
PD507 
PD1255 
PD1258 
PD1256 
PD278 
PD508 
PD1419 
PD1445 
PD1446 
PD445 
PD2762 
PD2763 
PD2764 
PD426 
PD1254 
PD1260 
PD1408 
PD2822 
PD2828 
PD2831 
PD2474 
PD2477 
NIZ096 
1310 
1361 
Race 
2 
2 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
Biovar 
1 
3 
3 
3 
3 
3 
4 
4 
1 
1 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
ELISAa 
ScFv 
-
+ 
-
-
-
-
-
+ 
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
PcA 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
jpb 
ScFv 
-
+ 
-
-
-
+ 
-
+ 
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
nd 
+ 
+ 
PcA 
nd 
+ 
nd 
nd 
nd 
nd 
nd 
+ 
nd 
nd 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
nd 
+ 
+ 
aELISA signals: - = reaction below background; and + = strong reaction (at least three times above 
background), 
bjF signals: - =no fluorescence; + = strong fluorescence; and nd = not done. 
Strains were obtained from Dr. J.D. Janse [Plant Protection Service (PD), Wageningen, the 
Netherlands] and Mrs A.C. Le Roux (INRA, Rennes, France). 
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The cross-reactivity of the recombinant antibodies was compared to PcA-9523, using a 
panel of plant pathogenic and saprophytic bacteria (Table 2.4) which had been shown to cross-
react with polyclonal antisera in ELISA, IF or immUnofluorescent colony staining. In ELISA 
and IF tests, scFvs cross-reacted with the banana blood disease bacterium (BBD), R. syzygii, 
Serratia fonticola, two strains belonging to the Enterobacteriaceae and with an unidentified 
bacterial strain: 1713, (Table 2.4). As was shown in Table 2.4, PcA-9523 cross-reacted with 
several bacterial strains that were not recognized by the scFvs. Thus, the specificity of the 
scFvs was higher than that of PcA-9523, the polyclonal antiserum that is used routinely for the 
detection of R. solanacearum in the Netherlands. 
Table 2.4. Comparison of the reactivity of monoclonal scFv (anti-LPS12) and polyclonal antiserum 
(PcA 9523) with various bacterial strains in ELISA and IF. 
Family3 , genus or species 
Ralstonia solanacearum 
Banana blood disease 
Ralstonia picketti 
Ralstonia syzygii 
Pseudomonas marginalis pv. 
Marginales 
Unknown 
Ochrobactrum antropi 
Rathayibacter tritici 
Bacillus macerans 
Aureobacterium liquefaciens 
Aureobacterium liquefaciens 
Serratia fonticola 
Ralstonia 
Unknown 
Ochrobactrum antropi 
Enterobacteriaceae 
Rhodococcus 
Xanthomonas maltophilia 
Erwinia herbicola 
Enterobacteriaceae 
Bacillus 
Rhodococcus 
Strain 
Origin 
Netherlands 
Sulawesi 
United Kingdom 
Indonesia 
France 
France 
Spain 
Spain 
Spain 
Spain 
Spain 
Spain 
Netherlands 
France 
Unknown 
Netherlands 
Netherlands 
Netherlands 
Netherlands 
Netherlands 
Netherlands 
Netherlands 
IPO 
number 
1609 
S303 
1720 
S302 
1714 
1713 
1682 
1690 
1691 
1692 
1693 
1694 
1723 
1715 
S306 
S339 
S340 
S341 
S343 
S345 
S346 
S347 
Original 
Number 
PD2763 
PD2100 
P r l l 5 0 
PD2093 
CFBP1538 
1531 
1521101 
15803 
15803 
15807 
158010 
1534.C 
PD2778 
R3 
PD2808 
PK15a 
PKlOa 
PK06b/b 
PK18a 
PK04a 
PK2/455 
PK2/76c 
Immunoassay 
ELISA b IF 0 
ScFv PcA ScFv 
+ + + 
+ + + 
+ 
+ + + 
+ 
+ + 
-
+ 
-
+ 
+ 
+ + + 
-
-
-
+ + + 
-
-
-
-
-
_ 
PcA 
+ 
+ 
+ 
+ 
-
-
+ 
-
-
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
+ 
+ 
_ 
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Family3, genus or species 
Unknown 
Bacillus polymyxa 
Ochrobactrum antropi 
Sphingobacterium multivorum 
Erwinia carotovora subsp. 
Carotovora 
Burkholderia andropogonis 
Burkholderia caryophylli 
Burkholderia caryophylli 
Burkholderia cepacia 
Burkholderia cepacia 
Burkholderia cepacia 
Burkholderia glumae 
Burkholderia plantarii 
Origin 
Sweden 
France 
United Kingdom 
Unknown 
France 
United Kingdom 
United Kingdom 
United Kingdom 
United Kingdom 
United Kingdom 
Unknown 
United Kingdom 
United Kingdom 
IPO 
number 
S348 
1721 
1722 
1717 
1710 
1704 
1705 
1701 
1702 
1703 
1718 
1708 
1707 
Original 
Number 
PK2/76b 
CFBP1954 
T-3b-7 
Rlc-3a 
233 
NCPPB1127 
NCPPB2151 
NCPPB353 
NCPPB945 
NCPPB946 
R5d-1 
NCPPB3708 
NCPPB3590 
ELISAb 
ScFv PcA 
-
-
+ 
-
_ 
+ 
+ 
-
-
+ 
-
+ 
-
IFc 
ScFv PcA 
+ 
-
-
-
+ 
-
+ 
+ 
-
-
-
+ 
+ 
aFatty acid analysis was used for strain identification and the best matches with the database of the 
Microbial Identification system are given. Sometimes, characterization was only up to family level as 
no closer match (at least 50 % identity) was found. Strains were obtained from Dr. J.D. Janse [Plant 
Protection Service (PD), Wageningen, the Netherlands], Dr. M.M. Lopez, rVIA, Valencia, Spain), Mrs 
A.C. Le Roux (INRA, Rennes, France) and Dr. J.G. Elphinstone (CSL, York, UK.). 
"ELISA signals: - = reaction below background; and + = strong reaction (at least three times above background). 
CIF signals: - =no fluorescence; + = strong fluorescence; and nd = not done. 
DISCUSSION 
Four different scFv antibodies were isolated from a combinatorial antibody library and 
evaluated for their utilization in a diagnostic assay for the detection of R. solanacearum race 
3. Three of these, anti-LPS 8, anti-LPS 12 and anti LPS 13 were promising candidates for 
routine application, as was based on their ease of production in E. coli and their specificity in 
IF and ELISA. The affinity of anti-LPS 12 was sufficient for sensitive detection of R. 
solanacearum, as threshold levels between 5 x 103 and 4 x 104 bacterial ml"1 were reached in 
ELISA and bright fluorescent staining was achieved in IF. 
The selected antibodies showed a higher degree of specificity than PcA-9523, the 
polyclonal antiserum that is used presently in routine testing. Apparently, the recognized LPS 
epitopes do not occur as frequently in the bacteria tested (Table 2.4) as other epitopes 
recognized by PcA-9523. Interesting is that all four different scFvs recognize the same 
bacterial strains and probably react with the same epitope. However, this was not validated, as 
no epitope mapping was carried out. The cross-reactions (Table 2.4) observed with BBD and 
R. syzygii will not compromise a diagnostic test for potato brown rot because these species are 
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not present in temperate areas where this test will be used. In contrast, the cross-reactions 
observed with the four other saprophytic bacteria from potato and soil can possibly cause 
false-positive results because they have been isolated in temperate areas. However, as the 
number of cross-reacting species is reduced relative to the PAbs in PcA-9523, it is to be 
anticipated that the use of these antibodies in seed testing will result in a decreased number of 
false positives. 
The sensitivity observed in ELISA, comparable to high quality PAbs, is promising. In IF 
relatively high quantities of scFv-antibody were required to obtain the same signal as the 
PAbs. This is probably because the scFv-antibodies have one antigen-binding site and bind 
monovalently to the antigen. In contrast, full size antibodies have two antigen binding sites 
that can bind with two epitopes simultaneously. According to Neri et al [19], this avidity 
effect can increase binding up to 100-fold and results in an improved performance in 
immunoassays. Single-chain antibodies can be engineered in a format allowing bivalent 
binding [21]. Bivalent molecules can also be established through a genetic fusion with E. coli 
alkaline phosphatase, a dimeric enzyme [13, 14]. Thus, if one of these avidity effects is added, 
it may further increase the sensitivity of the immunoassay. Alkaline phosphatase may be the 
most convenient choice for detection purposes. The production of scFv-enzyme fusion 
proteins may result in an improved reproducibility for the detection of antigens in various 
immunoassays since the variation due to repeated antibody enzyme conjugation is avoided. 
Engineering the format of scFvs might also be advantageous for the development of routine 
assays for the detection of R. solanacearum. Single-chain antibodies are small molecules that 
are often inactivated upon coating to ELISA plates [12]. Fusion to large proteins like 
gluthatione-S-transferase, amphipathic helices or to other immunoglobulin domains may 
enhance the coating efficiency while retaining the full binding activity [12]. 
The monoclonal recombinant scFvs described here are applicable in routine assays for R. 
solanacearum race 3, even though some cross-reactions with other species were observed. 
The selection of other anti-LPS scFvs that do not cross-react with these strains remains an 
option. The difficulty lies in the nature of the LPS of the cross-reacting bacteria. Although 
lipopolysaccharides are highly variable molecules, the possibility can not be excluded that 
LPS epitopes of cross-reacting bacteria are at least partially identical to the target bacteria. For 
the isolation of even more specific antibodies consideration may be given to outer membrane 
proteins or extracellular polysaccharides as antigens. We used a straightforward selection 
protocol that resulted in the most specific antibodies found thus far for R. solanacearum 
(biovar 2, race 3). However, phage display allows easy adaptation of the selection protocols, 
such as the inclusion of cycles of negative (against unwanted bacteria) and positive selection 
(for different races). In addition, the present antibody libraries cover the complete immune 
repertoire, in contrast to the hybridoma technology where only a part of the immune repertoire 
is tested. Antibody phage display in combination with protein engineering is highly promising 
for the selection of tailor-made monoclonal antibodies and can be combined with the design 
of improved immunoassays for phytopathogenic bacteria. 
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Chapter 3 
Selection of beet necrotic yellow vein virus specific single-chain Fv 
antibodies from a semi-synthetic combinatorial antibody Library 
ABSTRACT 
Methods for the generation of monoclonal antibodies against plant viruses are limited because 
current hybridoma techniques do not allow efficient exploitation of the immune repertoire. 
Moreover, the immunization procedures often lead to a bias towards an immunodominant 
contaminant in the immunogen preparation and not to the plant virus itself. The selection of 
six different single-chain antibody variable fragments (scFv) against beet necrotic yellow vein 
virus from a semi-synthetic human combinatorial antibody library showed the feasibility of 
the phage display system. No bias towards minor contaminants in the purified virus 
preparation was observed in ELISA, as all the selected scFvs reacted only with beet necrotic 
yellow vein virus infected plant homogenates. In addition, two of the isolated beet necrotic 
yellow vein virus-specific scFvs could be produced in E. coli as a scFv fusion protein with 
alkaline phosphatase, and were applied in ELISA as specific ready to use antibody-enzyme 
conjugates. Because of their specificity, these antibodies have potential to be used in sensitive 
diagnostic assays for routine testing for beet necrotic yellow vein virus in sugar beets. 
This chapter has been accepted for publishing in a modified form by the European Journal of Plant 
Pathology: Griep, R.A., Van Twisk, C. and Schots, A. Selection of beet necrotic yellow vein virus 
specific single-chain Fv antibodies from a semi-synthetic combinatorial antibody library. 
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INTRODUCTION 
Most diagnostic assays for plant viruses utilize polyclonal antibodies (PAbs) or monoclonal 
antibodies (MAbs). MAbs do have some advantages over PAbs. They are homogeneous and 
well defined reagents that allow standardization of assays between different laboratories 
[28,29]. Due to the fact that MAbs recognize single epitopes they may give less cross-
reactions, discriminate between viral strains [26,27] and MAbs directed against conserved 
epitopes may allow grouping of virus isolates for epidemiological and taxonomical studies. 
It is difficult to raise MAbs to some plant viruses because minor contaminants in the 
isolated virus fraction exhibit immunodominance [5]. This was shown to be the case for beet 
necrotic yellow vein virus (BNYVV), a furovirus causing rhizomania [24]. During 
purification the virus aggregates with host cell constituents [21] and only a few MAbs were 
obtained reacting specifically with BNYVV, while the majority of the MAbs reacted with 
healthy plant antigens. It is noteworthy that polyclonal antisera collected at the time of spleen 
removal had high virus-specific and low anti-healthy plant sap titers. The same phenomenon 
has been observed in developing MAbs to cauliflower mosaic virus [5] and blueberry red 
ringspot virus [6]. 
Various methods have been described to reduce the immune response to plant 
contaminants to enhance the yield of virus-specific MAbs. For instance, the induction of 
immunological tolerance in neonatal mice [8], the use of immunosuppressive agents like 
cyclophosphamide [14], or use of antigen based B-cell selection systems [20]. The common 
drawback of these methods is that the conditions have to be established for each virus. 
Current hybridoma methods [12] for the generation of MAbs against plant pathogens do 
not satisfactory exploit the immune repertoire. While the antibody repertoire is estimated to 
consist of over 108 different antibodies, only a few thousand different hybridoma clones are 
obtained, of which on average less then 1% produce antigen binding antibodies. Thus, the 
chance that a useful hybridoma derived MAb will be obtained is low. This diversity and 
efficiency problem was recently addressed by advances in molecular immunology. Forced 
cloning of DNA, encoding antibody variable heavy (VH) and light (VL) chain domains with 
reverse transcription PCR [19,23], allowed amplification of the antibody repertoire encoding 
sequences. Expression of VH and VL domains as a single-chain Fv (scFv) fusion protein (Fig. 
1.3) in E. coli was made possible by joining them with a flexible linker peptide [10]. Cloning 
of a pool of scFv encoding genes, in which VH and VL were randomly combined, enabled the 
generation of large combinatorial antibody libraries which have a diversity comparable to the 
natural immune repertoire [9,13]. This, in combination with the display of functional antigen 
binding fragments on the tips of filamentous phage, created a powerful system [3,7,15] to 
obtain specific MAbs. The phage display system (Fig. 1.6) allows direct selection of rare 
specificities from combinatorial antibody libraries through successive rounds of phage growth 
and selection for antigen binding. For instance, Bradbury and co-workers [1] showed the 
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feasibility of this technique by selecting antigen binding phages from a pool of non binding 
phages, even at a ratio of one binding in 109 irrelevant phages. In addition, the phage display 
system may also prove to be a more universal method to obtain specific MAbs, since the 
antibody specificities are not biased towards immunodominant epitopes. 
To study the versatility of the phage display system, we have applied it to BNYVV. This 
virus was chosen as a model system because it is a classic example of the difficulties outlined 
in raising specific MAbs. We examined the feasibility of the phage display system in isolating 
a diverse repertoire of BNYVV-specific antibody fragments from a semi-synthetic 
combinatorial antibody library [18]. 
MATERIALS AND METHODS 
Bacterial strains 
E. coli strains used for the isolation of recombinant antibodies, were TGI (K12, Mlac-pro), 
supE, thi, hsdD5/F'traD36, proA+B+, lacf, /acZAM15) for selection of specific phage-
antibodies and HB2151 (K12, ara, Mac-pro), thilF'/proA+B+, lacfZAMIS) for expression of 
soluble scFv-antibody fragments. HB2151 bacteria were grown at 30°C in 2TY containing 
100 ug ml"1 ampicillin and 2% (w/v) glucose [22]. When the OD60o reached 0.5, the bacteria 
were pelleted and the supernatant was discarded. The bacteria were resuspended in 2TY + 
AMP (100 ug/ml), induced with 1 mM IPTG and grown for 18 h at 16°C. 
Purification of beet necrotic yellow vein virions 
Beet necrotic yellow vein virus (Dutch isolate) was purified from mechanically inoculated 
Chenopodium quinoa according to a slightly modified protocol from Putz and Kuszala [21]. 
Infected C. quinoa leaves (200 g) were homogenized in a mixture of 400 ml CCU and 800 ml 
extraction buffer (0.1 M Tris/HCl buffer pH 9 containing 0.14 M NaCl; 5% (v/v) ethanol) and 
2% (w/v) polyvinylpyrrolidon. The mixture was stirred for 15 min at room temperature (RT) 
and then centrifuged for 15 min at 5,000 x g (GSA rotor, Sorvall). To the collected 
supernatant, 5% (w/v) PEG-8000 was added and stirred at RT for 15 min and subsequently at 
4°C for 90 min. The virions were pelleted at 16,000 x g (GSA, Sorvall) for 20 min. After 
resuspending the pellets in 100 ml extraction buffer and stirring overnight at 4°C, sucrose was 
added to 3.3% (w/v) and the mixture was centrifuged at 27,500 x g for 20 min (SW28, 
Beckman) to remove large aggregates. Subsequently the virions were pelleted at 110,000 x g 
(SW28, Beckman) for 2 h through a 3 cm layer of 20% (w/v) sucrose in extraction buffer. The 
pellets were resuspended in 50 ml extraction buffer and, after stirring for 30 min at RT, 
centrifuged for 10 min at 1,600 x g to remove insoluble precipitates. Half of the supernatant 
was adjusted to a density of 1.1 g/cm3, half to 1.3 g/cm3 with CsCl2. The two halves were 
layered 1:1 and centrifuged at 154,000 x g (SW41Ti, Beckman) for 18 h. The virions 
containing band was collected and dialyzed overnight against 0.1 M Tris/HCl buffer pH 9 
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containing 0.14 M NaCl and then centrifuged for 5 min at 12,000 x g to remove aggregates. 
The virion concentration was determined with a Beckman photospectrometer using a formula 
[(1552 x A2so) + (-757.3 x A260)], described by Warburg and Christian [30], which gives the 
protein concentration in ug ml"1. The concentration was adjusted to 1 mg ml'1 with 0.1 M 
Tris/HCl buffer pH 9 containing 0.14 M NaCl and 1 ml aliquots were frozen in liquid nitrogen 
and stored at -74°C until use. 
Expansion of the antibody library 
From a stock of the combinatorial library, which was constructed by Nissim et al [18], 50 ul 
was plated on a 240 x 240 mm minimal plate [22] to which ImM thiamin was added. The 
bacteria were grown overnight at 30°C, scraped from the plate and resuspended in 50 ml of 
2TY containing 100 ug ml"1 ampicillin and 1% (w/v) glucose. A freezer stock [22] was 
prepared from 10 ml of these bacteria. One bacterial OD60o unit was taken from the remaining 
40 ml, the volume adjusted to 10 ml by adding of 2TY containing 100 ug ml"1 ampicillin and 
1% (w/v) glucose, and the bacteria were grown at 37°C while shaking (250 rpm). When an 
OD6oo of 0.5 was reached, 1011 helper phages (M13K07, Pharmacia, Uppsala, Sweden) were 
added. The 15 ml tube containing the mixture was put in a waterbath without shaking to allow 
for optimal infection. After 30 min the bacteria were pelleted (2,100 x g, 10 min) and 
resuspended in 25 ml 2TY containing 100 ug ml"1 ampicillin and 25 jag ml"1 kanamycin. The 
bacteria were transferred to a 1 liter Erlenmeyer, with 225 ml of prewarmed (37°C) 2TY 
containing 100 ug ml"1 ampicillin and 25 ug ml"1 kanamycin, and were grown for 18 h at 30°C 
while shaking (250 rpm). 
Preparation of phage-antibodies for panning (large-scale production) 
The 250 ml overnight culture was harvested and the bacteria were removed by centrifugation 
(10,000 x g, 20 min, GSA, Sorvall). The phages in the supernatant were precipitated by 
adding 50 ml of 20 % (w/v) PEG-6000/ 2.5 M NaCl and mixed thoroughly for 1 h at 4°C. The 
precipitated phages were pelleted (8,000 x g, 40 min) and resuspended in 20 ml of sterile H20. 
Precipitation was repeated by adding 4 ml of PEG/NaCl and mixed for 20 min at 4°C. The 
phages were pelleted (17,000 x g, 10 min; SS34, Beckman), resuspended in 2.5 ml sterile H20 
and the stock was stored at 4°C for further use. Usually 5 x 1013 phages were produced, as was 
established by plating TGI bacteria on selective ampicillin plates after infection with serial 
dilutions of the phage suspension. 
Panning procedure 
Immunosorbent tubes (Maxi-sorb, Nunc) were coated with 40 ug BNYVV (10 ug ml"1 in 50 
mM NaHC03, pH 9.5) for 2 h on a rollerbench at 25°C and for another 18 h at 4°C. The tubes 
were washed 3 times with PBS and blocked with PBM (PBS containing 2% (w/v) skimmed 
milk powder) for 30 min. Simultaneously, 2 ml of phage-antibodies was mixed with 2 ml of 2 
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x PBM and preincubated for 30 min. After removing the blocking solution from the tubes, 4 
ml of the phage-antibodies containing PBM was added to an antigen-coated tube. Phage-
antibodies were allowed to bind to BNYVV for 30 min on a roller bench and for another 90 
minutes without rotation. Free phages were removed by washing the tubes 20 times with 4 ml 
PBS containing 0.1% (v/v) Tween-20 and for another 20 times with 4 ml PBS to remove the 
detergent. After washing the tubes were rinsed with 4 ml 0.1 M Tris/HCl pH 8.9 containing 
0.14 M NaCl. Bound phages were eluted by adding 1 ml of a 0.5 mg ml"1 BNYVV solution in 
0.1 M Tris/HCl pH 8.9 containing 0.14 M NaCl to the tube and incubated for 45 min with 
rotation, followed by a wash with 0.75 ml PBS. The BNYVV-eluted phages and phages in the 
PBS washing were pooled. One ml aliquot, of the BNYVV-eluted phages, was used to infect 
9 ml of E. coli TGI bacteria, for 30 min at 37°C in a water bath. The infected E. coli cells 
were pelleted (2,100 x g, 10 min) and subsequently resuspended in 1 ml of 2TY, containing 
100 ug ml"1 ampicillin and 1% (w/v) glucose. From these suspensions 50 ul aliquots were 
taken and plated in serial dilutions on 2TY agar plates containing 100 ug ml"1 ampicillin and 
1% (w/v) glucose to establish the number of eluted phages and to make freezer stocks [22] of 
TGI bacteria which were growing in single colonies. The remaining 950 ul was plated 
separately on 240 x 240 mm minimal plates [22] to which 1 mM thiamin was added, and 
grown for 18 h at 30°C. Further enrichment of BNYVV-specific phage-antibodies was 
achieved by three additional panning rounds, which were performed according to figure 1.6. 
Preparation of phage-antibodies for ELISA (medium-scale production) 
From a streak of the bacterial freezer stocks, prepared during the panning procedure, single 
colonies were tooth picked and plated on minimal plates [22] to which ImM thiamin was 
added. The bacteria were grown for 18 h at 30°C, scraped from the plate and resuspended in 2 
ml of 2TY containing 100 ug ml"1 ampicillin and 1% (w/v) glucose. One bacterial OD60o unit 
was adjusted to 1 ml by adding of 2TY containing 100 ug ml"' ampicillin and 1% (w/v) 
glucose, and 2 x 1010 helper phages (M13K07, Pharmacia). The 1.5 ml Eppendorf tube 
containing the mixture was put in a waterbath for 30 min without shaking to allow for optimal 
infection at 37°C. The bacteria were pelleted (8,000 x g, 10 min) and resuspended in 750 ul 
2TY containing 100 ug ml"' ampicillin and 50 ug ml"' kanamycin. The bacteria were 
transferred to a 24-well culture plate and grown for 18 h at 30°C while shaking (100 rpm). 
The 750 ul overnight culture was harvested and the bacteria were removed by centrifugation 
(8,000 x g, 10 min). If necessary, the phages in the supernatant were precipitated by adding 
150 ul of 20% (w/v) PEG-6000/2.5 M NaCl and mixing well for 1 h at 4°C. The precipitated 
phage-antibodies were pelleted (8,000 x g, 10 min), resuspended in 250 ul of PBM and stored 
at 4°C until further use. 
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Preparation of phage-antibodies for ELISA (small-scale production) 
After each panning round, 100 single colonies were picked and inoculated in 100 ul of 2TY 
containing 100 ug ml"1 ampicillin and 1% (w/v) glucose in a well of a 96-well culture plate. 
To study the effect of the panning also 100 single colonies were picked from the original 
library before any selection was carried out (Panning round 0). The bacteria were grown 
shaking (200 rpm) for 18 h at 30°C. From these overnight cultures 5 ul was taken, inoculated 
in a new 96-well plate well, containing 100 ul of 2TY with 100 ug ml"1 ampicillin and 1% 
(w/v) glucose and grown shaking for 1 h at 37°C. To allow super-infection, 50 ul aliquots of 
2TY containing 100 ug ml"1 ampicillin, 1% (w/v) glucose and 2.5 X 109 helper phages 
(M13K07, Pharmacia) were added to each well and incubated for 30 min without shaking and 
for 1 h with shaking (200 rpm) at 37°C. The bacteria were pelleted (2,800 x g, 10 min) and 
resuspended in 200 ul 2TY containing 100 ug ml"1 ampicillin and 50 ug ml"1 kanamycin. The 
bacteria were grown shaking (200 rpm) at 30°C for 18 h, removed by centrifugation (2,800 x 
g, 10 min) and the phage-antibody containing supernatant was stored at 4°C until further use. 
Phage-ELISA 
The phage-ELISA was essentially carried out according to Clark and Adams [4] and to Tijsen 
[25]. Briefly, ELISA plates (Labstar, Costar, Cambridge, UK) were coated overnight with 100 
Hi of polyclonal rabbit-anti-BNYVV antibodies (3 ug IgG ml"1 in 50 mM NaHC03, pH 9.5) at 
4°C. The plates were washed with PBST (PBS containing 0.1% (v/v) Tween-20) and blocked 
with PBM for 30 min at 37°C at 200 ul per well. The microtiter plates were washed twice 
with PBST and incubated for 1 h at RT with 100 ul/well of a C. quinoa leaf homogenate (50 
mg dry leaf material ml"1 in PBM), with or without BNYVV lesions. After each incubation 
step the microtiter plates were washed four times with PBST. The plates were subsequently 
incubated for 1 h at RT with phage samples, diluted 1:1 in PBM; with polyclonal mouse-anti-
M13 antibodies, diluted 1:10,000 in PBM; and finally with polyclonal rat-anti-mouse 
antibodies conjugated to alkaline phosphatase (Jackson Immuno-Research Laboratories, Inc., 
Westgrove, PA) diluted 1:2500 in PBM at 100 ul per well. The ELISA was developed by 
adding 100 u I p-nitrophenylphosphate substrate per well and absorbance readings were made 
at 405 nm, usually within 60 min. A reaction in phage-ELISA was considered to be positive if 
the threshold value (mean of the background + three times the standard deviation) was 
exceeded. 
Mval-fingerprinting 
Fingerprinting was performed on PCR amplified scFv-DNA using the restriction enzyme 
Mval. Single colonies were tooth picked and grown for 4 h in 2TY containing 100 ug/ul 
ampicillin and 1% (w/v) glucose. The bacteria were boiled for 3 min and pelleted at 14.000 x 
g for 10 min. From the supernatant 2 ul was added to a 48 ul PCR mix containing 2.5 uM 
dNTPs; 0.25 U Super Taq DNA polymerase (HT Biotechnology, Cambridge, UK); 10 uM 
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Forward primer (5'-AGG AAA CAG CTA TGA CCA TGA TTA CGC CAA G-3') and 10 uM 
Backward primer (5'-GCC CAA TAG GAA CCC ATG TAC CGT AAC ACT G-3'); 2 mM 
MgCl2 and 50 mM Tris/HCl, pH 8 and 25 cycles (1 min 94°C; 2 min 72°C) were performed 
on a thermal cycler (Perkin Elmer). From the PCR mix, 20 pi was added to 36.5 pi H20 and 
6,5 ul of buffer H (Boehringer, Mannheim, Germany). After mixing 2 ul (lU/jil) Mval 
(Boehringer) was added and incubated 18 h at 37 °C. The Mval digestion patterns were 
analyzed on a 3% FMC Metaphor agarose gel (Epicentre Technologies, Madison, USA). 
Cloning of scFvs into pDAP2/S 
The genes encoding the scFvs, BNY-8 and BNY-10, were PCR amplified using the forward 
and backward primers, HindUi and Notl digested, gel purified, ligated into HindWNotl 
digested pDAP2/S vector [11] and transfected to E. coli TGI bacteria. Transformed bacteria 
were picked and tested for the expression of scFv-alkaline phosphatase fusion-proteins 
through incubations with p-nitrophenyl phosphate. 
Production of scFv-AP/S fusion-proteins 
Cultures were grown and induced as described by Kerschbaumer and co-workers [11]. 
Pelleted bacteria (5,000 rpm in a GSA rotor during 20 min at 4°C) were resuspended in 1/20 
volume (referring to the original culture size) of a 50 mM Tris/HCl pH 8 buffer (containing 
30% sucrose and 1 mM EDTA). After incubation for 5 min at 0°C the bacteria were pelleted 
(10,000 rpm in a GSA rotor during 20 min at 4°C) and the produced proteins were extracted 
by an osmotic shock from the periplasm with 1/20 volume (referring to the original culture 
size) of 5 mM MgS04 and incubation for 45 min at 0CC. The bacterial debris was removed by 
centrifugation. 
ELISA 
An antigen coated plate (ACP)-ELISA was used to assess the specificity of the recombinant 
scFv-AP2/S fusion proteins in the osmotic shock fractions according to standard methods, in 
which the plates were washed four times between each incubation. Briefly, the wells of a 96 
well microtiter plate were coated with the appropriate antigen in 0.1 M NaC03 pH 9.6) for 2 h 
at 37°C. After blocking with PBMT-5% (PBS containing 5% skimmed milk powder and 0.1% 
Tween-20) at 200 ul/well for 30 min at 37°C, the wells were incubated with scFv-AP2/S 
diluted in 100 ul of PBMT-1% for 1 h at 37°C. The reaction was visualized by a subsequent 
incubation with p-nitrophenylphosphate. 
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RESULTS 
Selection of BNYW binding clones from a phage-antibody library 
To select BNYVV-specific monoclonal antibodies, scFv expressing phages were rescued from 
a semi-synthetic human antibody library containing 108 different antibody encoding 
phagemids [18], and subjected to panning. The rescued phages, containing 1013 phage-
antibodies (PhAbs), were allowed to bind to immobilized BNYW particles. Bound PhAbs, 
were eluted by specific elution with competing antigen. To monitor the efficiency of selection 
during the panning experiments, the phage recovery was measured after each panning round. 
Determination of the phage recovery (Fig. 3.1 A) showed a clear enhancement. Especially in 
the third round where a strong increase in phage recovery, about 1,000 fold, was found. 
Because the fourth panning round did not show a further increase in phage recovery, a fifth 
selection round was not applied. 
A B C 
1 2 3 4 
Panning round 
0 1 2 3 4 
Panning round 
0 1 2 3 4 
Panning round 
Figure 3.1. Recovery and specificity of BNYVV-binding phage-antibodies in four sequential rounds of 
panning. A) The number of recovered PhAbs was counted and the recovery was plotted for each 
subsequent panning round. B) Phage-antibodies were produced (medium-scale production) and 
comparable amounts were tested in polyclonal phage-ELISA. Phage-antibodies that were rescued from 
a stock of the antibody library before any selection had been applied served as negative control 
(panning round 0). C) In addition the percentage of BNYVV-specific phage-antibody producing clones 
(small-scale production) was shown by a monoclonal phage-ELISA. Colonies were counted positive in 
case the derived signal exceeded the mean (n=3) of the negative control pHen (non-scFv expressing 
phage) plus three times the standard deviation. 
To verify if any of the selected phage-antibodies were BNYVV-specific, a polyclonal 
sandwich phage-ELISA was carried out with samples taken from the stocks of phage-
antibodies which were prepared by large-scale production for each panning round. In this 
BNYVV-specific phage-ELISA, the polyclonal PhAbs showed increasing signals for 
subsequent rounds of panning (data not shown). The same stocks of polyclonal PhAbs were 
also tested for their reactivity using a phage-ELISA format in which purified BNYW was 
coated directly to the plate. Although the signals from the sandwich ELISA were stronger than 
those obtained from the ACP phage-ELISA (data not shown), both ELISAs showed a similar 
increase. To ensure that differences in ELISA signals could be contributed to enhancements in 
specificity and not to degradation of the oldest samples during storage, and to allow the PhAbs 
obtained from the fourth selection round to be included in the ELISA as well, PhAbs were 
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rescued simultaneously from the freezer stocks of the bacteria. When comparable amounts of 
PhAbs were tested in ELISA, again an increase in BNYVV binding was observed up to the 
third panning round (Fig. 3.IB). This seemed to be a superlative level, as the signal showed 
no further increase after the fourth round of selection. 
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Figure 3.2. A) Restriction patterns of BNYVV binding clones which were obtained during selection. 
PCR-products (1100 Bp) of the DNA encoding the BNYVV-specific antibody fragments were digested 
with the restriction enzyme Mval. The digested fragments were analyzed on a 3% FMC metaphor 
agarose gel. B) The specificity of the isolated PhAbs for BNYVV is shown in a phage-ELISA with 
homogenates of healthy and BNYVV-infected C. quinoa leaf material. Supernatants of infected E. coli 
cultures were tested directly for BNYVV specificity in the phage-ELISA after 1:5 dilution in PBM. 
Rescued (non-scFv expressing) phages, obtained from TGI bacteria which were transformed with a no 
scFv containing phagemid (pHen), served as a negative control. 
Characterization of BNYVV-specific phage-antibodies 
The polyclonal character of the phage-ELISA does not give a clear image of the antibody 
specificity because of different growth rates and expression levels between individual clones. 
Therefore, 100 single clones were isolated from each panning round. The monoclonal phage-
antibodies, produced by these individual clones, were tested separately in a phage-ELISA 
(Fig. 3.1C) and showed a strong increase in the number of positive clones from zero % before 
selection to as much as 30% after the fourth round of selection. 
To investigate the diversity within the selected monoclonal phage-antibodies, a DNA 
fingerprint was carried out. The scFv encoding DNAs, of the clones that were positive in the 
phage-ELISA, were amplified by PCR and digested with the restriction enzyme Mval. When 
the digestion products were analyzed on an agarose gel (Fig. 3.2A), a high variation was 
observed within the isolated monoclonal phage-antibodies. A total of six different Mval-
patterns was found within the positive clones. These monoclonal PhAbs were designated 
BNY-1, BNY-2, BNY-3, BNY-5, BNY8 and BNY-10, of which PhAb BNY-10 had become 
the most abundant PhAb after three rounds of selection. Up to 90% of the positive colonies 
possessed the same Mval restriction pattern as PhAb BNY-10. In contrast, after four rounds of 
selection PhAbs like BNY-2, BNY-3 and BNY-5 had completely disappeared from the 
antibody pool. 
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To study the specificity of the selected MAbs towards healthy and BNYVV infected C. 
quinoa plants, one representative colony of each pattern was selected, streaked and after 
phage-antibody production tested for its reactivity in a phage-ELISA (Fig. 3.2B). Of the 
isolated PhAbs, five gave high reactions with BNYVV infected plants but no reaction with 
healthy C. quinoa plants in the BNYVV-specific phage-ELISA. The only MAb that failed to 
give a positive reaction in this ELISA corresponds to the restriction pattern of MAb BNY-2 
that was found in a positive colony obtained from the first panning round but nowhere else. 
However, when the phage-ELISA was repeated with a PEG-purified and concentrated BNY-2 
phage-antibody, a positive signal was found for BNYVV infected but not with healthy C. 
quinoa (Fig. 3.3B: BNY-2p). 
Although the selected monoclonal phage-antibodies reacted specifically with BNYVV in a 
phage-ELISA, they failed when they were expressed in E. coli strain HB2151 as soluble scFv 
antibodies. When the HB2151 bacteria were fractionated after induction with IPTG, and tested 
by Western blotting for the presence of expressed scFvs, high signals were found within the 
cytoplasm (data not shown) but not within the periplasm. Apparently the transport of the 
scFvs to the periplasm is troublesome and the result is formation of inclusion bodies. An 
improvement was observed when the scFv genes of BNY-8 and BNY-10 were recloned into 
the expression vector pDAP2/S [11] which allowed the scFvs to be expressed as scFv-alkaline 
phosphatase fusion proteins (scFv-AP/S) that were subsequently secreted into the periplasm 
(Fig. 3.3). After extraction of the scFv-AP/S fusion proteins from the periplasm, specific 
signals were obtained in ELISA with extracts of BNYVV-infected plants (Fig. 3.4). 
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Figure 3.3. A) Expression of scFv-AP/S fusion proteins in Escherichia coli. B) Alkaline phosphatase 
activity in the osmotic shock fractions of non-fused AP/S, BNY8-AP/S and BNY10-AP/S was 
measured 10 minutes after the addition of 10 ul osmotic shock fraction to 100 ul of p-NPP substrate, 
where 10 pi of 5mM MgS04 served as the negative control (NC). 
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Figure 3.4. A) Outline of BNYVV-specific ELISA. The ELISA plate was coated either with a healthy 
or BNYVV infected C. quinoa homogenate. B) For detection of BNYVV, scFv alkaline phosphatase 
fusion proteins (BNY8-AP/S, BNY10-AP/S) or non-fused alkaline phosphatase (AP/S) were used and 
binding of the bifunctional antibody-enzyme conjugate was visualized with p-NPP substrate. 
DISCUSSION 
Six different BNYVV-specific monoclonal phage-antibodies were selected from a semi-
synthetic human combinatorial antibody library [18], as was assayed by Mval digestion of 
PCR amplified scFv encoding DNA. Each of these PhAbs reacts specifically with BNYVV 
from C. quinoa leaf homogenates in a sandwich ELISA. When the phage display technique is 
compared to the hybridoma technique a number of advantages are observed. First, laboratory 
animals are no longer required. Second, selection of antibodies from semi-synthetic 
combinatorial antibody libraries with phage display is much faster and less labor-intensive. 
Third, there is no bias towards certain minor plant contaminants in the antigen preparation. 
Finally, the specificity and affinity of the MAbs can be guided in a certain direction through 
manipulations during selection. For instance, high affinity antibodies can be obtained using 
low amounts of antigen or the specificity can be enhanced by elution with competing antigen. 
Although elution with competing antigen gave a steep rise in BNYVV-binding PhAbs in 
the described selection procedure (Fig. 3.1C) and finally yielded a high PhAb diversity, it 
generally has the disadvantage to select for antibodies with high dissociation rates. Another 
disadvantage is the high amount of antigen that is required for elution: over 2 mg of purified 
BNYVV was required for four rounds of panning and elution. If the antigen is merely used for 
coating of the immunosorbent tubes then only 160 ug is needed. However, in cases where 
non-specific binding of the filamentous phage to the antigen is high, as was found for 
BNYVV in a pilot study, specific elution might be the only way to enrich for target-specific 
PhAbs during panning. 
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When the goal of selection is to obtain a diverse repertoire of antigen-specific antibodies 
with regard to recognition of different epitopes on the antigen or sets of scFvs recognizing the 
same epitope, care should be taken not to lose antibody diversity through applying too many 
rounds of selection. The percentage of positive clones improved with each subsequent round 
of panning (Fig. 3.2C) and 30% was reached after four rounds of selection. When more 
subsequent rounds of selection would have been performed the 100% would probably have 
been reached. However, a decrease in the diversity was observed after the third round of 
selection. This indicates that too many rounds of selection results either in antibodies with the 
highest affinity for the most abundant epitope or in antibodies which are produced at a faster 
rate and which are not necessarily the most specific. 
The inability of E. coli to export the selected BNYVV-specific scFvs to the periplasm was 
observed. Several mutations are known which can enhance the transport of scFvs to the 
periplasm [17] and it might be worthwhile to introduce these mutations into the BNYVV-
specific antibodies. The presence of an E. coli protein domain (AP/S) on the C-terminus of the 
scFv molecule already seemed to increase the stability and the folding efficiency of the 
soluble scFv. In addition, the dimeric character of alkaline phosphatase may also add an 
avidity factor to the affinity of the scFv-AP/S fusion protein for the antigen. Moreover, 
production of MAbs in E. coli offers several important features for the standardization of 
detection assays. Production of scFv-enzyme fusion proteins might give a better 
reproducibility of the detection of antigens in various immunoassays since the highly variable 
step of antibody enzyme conjugation is omitted. The recombinant scFv antibodies can be 
purified via co-expressed affinity tags [2,16] to yield ultra pure, ready to use alkaline 
phosphatase conjugated reagents. 
It is interesting that all the scFv expressing clones isolated with the phage display 
procedure are BNYVV-specific and do not react with antigens from the C. quinoa 
homogenate. Phage display rather allows PhAbs to be selected on the presence of a specific 
epitope than on the basis of immunogenicity. For example, glycoproteins are highly 
immunogenic. Therefore, the immune response elicited by a virus preparation that is slightly 
contaminated with a plant glycoprotein will be biased to that particular glycoprotein. The 
result is a high proportion of host-specific MAbs. If the same virus preparation would be used 
to select PhAbs from a combinatorial antibody library, specific clones are obtained against the 
most abundant epitope present; i.e., the virus. This was what was observed for the BNYVV 
virus preparation, the virus is almost pure but still contains some plant contaminants, yet the 
PhAbs obtained with this method are BNYVV-specific. It would be worthwhile to evaluate 
their use in a routinely applied standardized detection assay for BNYVV in sugar beets. They 
certainly have potential, as they are highly BNYVV-specific. 
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Chapter 4 
pSKAP/S: an expression vector for the production 
of single-chain Fv alkaline phosphatase fusion proteins 
ABSTRACT 
The vector pSKAP/S, was constructed to enable overexpression of single-chain variable 
fragment antibody (scFv)-alkaline phosphatase fusion proteins. In pSKAP/S, the scFv were 
genetically fused to the mutated Escherichia coli PhoA/S gene that encodes an alkaline 
phosphatase with increased specific activity. The restriction sites incorporated into pSKAP/S 
allowed the scFv genes to be easily transferred from pUC119-derived phagemid vectors, that 
are used frequently in phage display antibody library technology. Strong transcriptional control 
of expression was achieved using the tetracycline promoter, and induction of different 
individual clones with anhydrotetracycline resulted in secretion of most of the scFv-alkaline 
phosphatase fusion proteins into the culture medium. Although some of the clones secreted 
fusion proteins that were retained in the periplasm, these proteins could be isolated with a 
simple extraction procedure. Increased amounts of a scFv-alkaline phosphatase fusion protein 
were obtained when expressed in the pSKAP/S vector compared with expression in a vector 
incorporating the lac promoter. Testing for binding of the scFv-alkaline phosphatase fusion 
proteins to antigen was possible in an ELISA without the need for additional enzyme-
conjugated antibodies. The pSKAP/S vector was successfully used to obtain scFv fragments 
from a preparation of phage-antibody clones after sub-cloning and expression of individual 
clones as scFv-alkaline phosphatase fusions, whereas fewer clones (and clones with different 
properties) were obtained from the same phage-antibody preparations when expressed as 
soluble scFv fragments. Therefore, the pSKAP/S vector was shown to be useful in extending 
the range of scFv obtained from phage display libraries. 
This chapter has been accepted for publication in a modified form by the Journal Protein Expression 
and Purification: Griep, R.A., Van Twisk, C, Kerschbaumer, R.J., Harper, K., Torrance, L., Himmler, 
G., Van der Wolf, J.M. and Schots, A. pSKAP/S: an expression vector for the production of single-
chain Fv alkaline phosphatase fusion proteins. 
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INTRODUCTION 
Recombinant antibodies with unique binding specificities can be selected from large 
combinatorial phage display single-chain variable fragment (scFv) antibody libraries. The 
phage-antibodies are selected by successive rounds of binding to antigen, elution and growth 
of the eluted phage in Escherichia coli without the need for animal immunization 
[6,9,20,22,27]. Usually, binding of recombinant antibodies to antigen is detected by means of 
linked peptide-tags (for example, c-myc [9], Flag [10], E-tag, Pharmacia). However, 
sometimes inconsistencies are observed upon analysis of the soluble scFv obtained. For 
example, soluble scFv-c-myc antibodies, selected against beet necrotic yellow vein virus 
(BNYVV: Chapter 3) and potato leafroll virus (PLRV), failed to bind to their respective 
antigens (Unpublished results). Yet, various scFvs, derived from the same selection process, 
bound specifically to their antigens when expressed on filamentous phage. 
Single-chain Fv comprise the variable domains of the heavy and light chains of 
immunoglobulin molecules connected by a short peptide sequence (c. 10-15 amino acid 
residues). It may be that some scFv-c-myc fusion proteins do not fold properly [21] because 
the hydrophobic residues of the variable/constant domain interface, that are normally shielded 
in the whole antibody molecule by the constant domains of the heavy and light chains, are 
exposed in the scFv molecule. Fusion of scFv to the pUI coat protein of filamentous phage may 
mimic the shielding effect of the hydrophobic residues. In addition, several scFvs may be 
expressed on a single phage particle, thereby increasing the avidity of binding to antigen, in 
contrast to the monomeric scFv-c-myc. 
The expression of scFv-alkaline phosphatase (scFv-AP) fusion proteins promotes the 
formation of bivalent antibodies, due to the dimeric nature of active alkaline phosphatase (AP., 
[1,4,7,12,13,15,26,28,29]). Moreover, the use of an improved alkaline phosphatase enzyme 
(AP/S) with a reported 35-fold higher specific activity [18] compared to the E. coli wild-type 
protein, increases the absorbance values obtained in ELISA [12]. 
In addition, increased levels of expression of scFv are possible through improvements to 
the expression vector. Although the lac promoter is used frequently, it is known to be leaky, 
and cell lysis often occurs prior to induction of protein expression by IPTG [24]. In contrast, 
the TetA tetracycline promoter/operator of the TnlO TcR gene (reviewed by Hillen and Berens, 
[8]) is strongly controlled and has been used to express antibody fragments in E. coli [25]. 
Therefore, the vector pSKAP/S was constructed to enable strongly regulated expression of 
scFv-AP/S fusion proteins, under the transcriptional control of the TetA promoter in E. coli. 
The results presented in this paper demonstrate the utility of application of pSKAP/S to the 
expression of a variety of scFv. 
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MATERIALS AND METHODS 
Bacterial strains 
E. coli strains used for the expression of scFv-AP/S fusion proteins were TGI (K12, A(lac-
pro), supE, thi, hsdD5/F'traD36, proA+B+, lacP, facZAM15) and XLl-Blue MRF' Kan 
(Stratagene) (K12, A(mcM)183, A(mcrCB-hsdSMR-mrr)173, endAl SupE44 thi-l recAl 
gyrA96 relAl, lac F' proAB lacfZAMIS Tn5 (Kanr)). 
pSKAP/S 
t c t a g t aa^i rtt g ca t g c a a a t t c t a t t t c a a g ga g 
H i n d l l l 
/ PEL-B l e a d e r 
M K Y L L P T A A 
a c a g t c a t a ATG AAA TAC CTA TTG CCT ACG GCA GCC 
A G L L L L A A Q P A M 
GCT GGA TTG TTA TTA CTC GCG GCC CAG CCG GCC ATG 
S f i l 
. . . / P o l y l i n k e r / . . . S p a c e r . . 
A Q V Q L Q A R L A A A 
GCC CAG GTG CAG CTG CAS GCG CGC CTG GCG GCC GCA 
P s t I Asc I NotI 
. . . / A l k a l i n e p h o s p h a t a s e / 
A R A P L G D I A H H 
GCC COG GCA CCA CTG GGG GAT ATC GCA CAC CAT 
Xmal EcoRV 
His-tag. ./STOP/ pSKAP/S 
H H H H -
CAC CAT CAC CAT TAA GGA TCC gaa ttc tga get tga 
BanHI 
B 
'amHI 
Figure 4.1. A) Genetic organization, and sequence of the multiple cloning site of pSKAP/S. B) The 
arrows show the position of the TetA promoter (P) and the genes encoding mutated alkaline 
phosphatase (AP/S), ampicillin resistance (AMP11) and the tetracycline repressor (TetR). The 
restriction sites that were used for the construction of this vector are shown and the insertion sites for 
chloramphenicol acetyltransferase signal peptide (CAT) and scFv encoding DNA fragments are 
indicated. 
Construction of pSKAP/S 
The adapters ASK51 (5'-CTA GTA AGC TTC TAG AGG ATC CGA ATT CTG-3') and 
ASK52 (5'-AGC TCA GAA TTC GGA TCC TCT AGA AGC TTA-3') were mixed to 
introduce a new multiple cloning site into pASK75 [25]. After heating for 10 min at 94CC, 
they were cooled slowly to room temperature and ligated (10:1 molar ratio) into the Xbal and 
HindUl digested vector fragment of pASK75. This removed the Xbal and the HindUl sites 
from pASK75 and introduced a new multiple cloning site (Fig. 4.1). The resulting vector 
(pSK) was transfected to E. coli XLl-blue MRF' Kan bacteria (Stratagene). The purified pSK 
53 
vector was isolated from pooled transformed bacteria and digested with HindlE and BamHl. 
The optimized PelB-AP/S fragment [12] was HindWBamHl digested, ligated into pSK, 
transfected to E. coli XLl-blue MRF' Kan bacteria and grown overnight at 37°C on selective 
agarose plates (containing 100 |ig AMP/ml LB agarose). 
Induction of expression in pSKAP/S 
Individual transformants were picked and grown overnight at 28°C in LB medium (100 ug 
AMP/ml). Prior to induction the bacteria were diluted 1:100 in 2TY medium (100 ug 
AMP/ml) and grown at 37°C. When the cultures had reached late log-phase, the temperature 
was decreased to 16°C for 1 h. Then anhydrotetracycline (aTc) was added (0.2 ug/ml final 
concentration) and the bacteria were grown for 18 additional hours and tested for alkaline 
phosphatase activity. For this, 10 ul of the bacterial suspension was added to 200 ul p-
nitrophenyl phosphate substrate and incubated at room temperature. 
Cloning of scFv into pSKAP/S 
Preparations of phage-antibodies (from a combinatorial library) were obtained after four 
rounds of selection on antigen were used to infect E. coli XLl-blue MRF' Kan bacteria 
(Stratagene) which were then plated on selective LB plates (100 ug AMP/ml) and grown 
overnight. The plasmids were purified (Midiprep, Promega) digested with HindTH and Notl 
and the scFv-encoding DNA fragments were ligated into HindWNotl digested pSKAP/S 
vector and transfected to E. coli XLl-blue MRF' Kan bacteria. Clones expressing anti-PLRV 
scFv were expressed in E. coli TGI cells. Transformed bacteria were picked and tested for the 
expression of scFv-AP/S fusion proteins as described above. 
Purification of scFv-AP/S fusion proteins 
Bacteria were pelleted and then resuspended in 1/20 of the original culture volume, of 50 mM 
Tris/HCl pH 8 buffer, containing 30% sucrose and 1 mM EDTA. After incubation for 5 min at 
0°C, the bacteria were pelleted and subjected to osmotic shock by the addition of 1/20 the 
original culture volume of 5 mM MgS04 and incubated for 45 min at 0°C. The bacterial debris 
was pelleted and residual EDTA was removed from the resultant soluble periplasmic extract 
through a buffer exchange, using a G25 gel permeation column (Pharmacia). The (His)6-tagged 
scFv-AP/S fusion proteins were purified with immobilized metal affinity chromatography 
(IMAC) using Zn2+ charged chelating Sepharose (Pharmacia, Uppsala, Sweden) according to 
Lindner et al [16]. Bound proteins were eluted with PBS containing 250 mM imidazole and 1 
M NaCl. 
ELISA 
An indirect ELISA was used to assess the specificity of the scFv-AP/S fusion proteins 
according to standard methods. Briefly, the wells of a 96-well microtiter plate were coated 
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with the appropriate antigen (2 ug/ml in 0.1 M Na2C03) for 2 h at 37°C. After blocking with 
PBTM-5% (PBS containing 0.1% Tween-20 and 5% skimmed milk powder) at 200 ul/well for 
30 min at 37°C, the wells were incubated with scFv-AP/S diluted in 100 ul of PBTM-1% for 1 
h at 37°C. The reaction was visualized by incubation withp-nitrophenyl phosphate. For PLRV, 
this was done as previously described [7]. 
BIAcore measurements 
Binding of isolated scFv-AP/S fusion proteins to lipopolysaccharides (LPS) of Ralstonia 
solanacearum was analyzed using a BIAcore 2000 (Pharmacia Biosensor [11]). Streptavidin 
(10 ug/ml in 10 mM sodium acetate buffer of pH 4.6) was immobilized using the amine 
coupling kit from the manufacturer with a contact time of 10 min at a flow rate of 10 ul/min, 
yielding about 1100 response units (RU). The microsensor chip was then incubated with 
biotinylated LPS (biotinylated with LC-biotinhydrazide according to the protocol of the 
manufacturer, Pierce) until saturation was observed (5000 RU). For measurement of the 
association kinetics, 10 ul of purified scFv-AP/S (0.2 ug scFv-AP/S per ml) was applied at 10 
ul/min. Dissociation kinetics were observed for three minutes. Between each measurement the 
microsensor chip was washed subsequently for 30 s with NaOH (lOOmM; 10 ul/min) and 30 s 
with HC1 (100 mM; 10 ul/min) for regeneration. 
RESULTS 
To construct pSKAP/S, the alkaline phosphatase gene containing a mutation that enhances the 
specific activity of the enzyme 35-fold, was recloned into the vector pSK (Fig. 4.1). The 
resulting pSKAP/S vector that contains a tetracycline-inducible promoter/operator region was 
used to express AP/S on induction with different amounts of aTc. ATc is a tetracycline 
analogue that can induce protein expression more strongly than tetracycline although it has less 
antibiotic activity. The 7efA-promoter was fully derepressed on addition of 100 ng aTc ml"1 
(Fig. 4.2A). The scFv BNY10, specific for BNYVV, could not be expressed as a functional 
scFv-c-myc fusion protein. However, after subcloning and expression into pSKAP/S, 
functional BNY10-AP/S fusion proteins that detected BNYVV in ELISA were produced (Fig. 
4.2B). A direct comparison was made of the amounts of murine hybridoma-derived BNYVV-
AP/S fusion protein [12] obtained after expression in the vectors pDAP2/S [13] and pSKAP/S. 
The relative amounts of the scFv-alkaline phosphatase fusion proteins expressed were 
compared by measuring alkaline phosphatase activity in the bacterial culture supernatant 
fluids. Expression levels were greater in cells harboring pSKAP/S in both TGI and XLl-Blue 
MRF' bacterial strains (Fig. 4.2C). In addition, secretion of several other scFv-AP/S fusion 
proteins into the periplasm was also higher in the XL 1-blue MRF' E. coli cells than in TGI E. 
coli cells (data not shown). 
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Figure 4.2. A) Induction of pSKAP/S with various amounts of anhydrotetracycline (aTc). The 
pSKAP/S vector produces either non-fused alkaline phosphatase (AP/S) or a fusion protein of AP/S 
with a single-chain variable fragment (BNY10-AP/S) directed against beet necrotic yellow vein virus 
(BNYVV). B) ELISA for testing of AP/S and BNY10-AP/S using either healthy or BNYVV-infected 
plant extracts for coating microtiter plates. C) Comparison of the expression (as judged by alkaline 
phophatase activity within the supernatant) of a murine scFv-AP/S fusion protein in the expression 
vectors pSKAP/S and pDAP2/S and the influence of the E. coli TGI and XLl-Blue MRF' Kan strains 
which were used for overexpression. 
Table 4.1. Reactivity (number and percentage) of single-chain variable fragments (scFv) derived from 
a selection against potato leafroll virus (PLRV). ScFv were expressed on phage, as scFv-c-myc or as 
scFv-alkaline phosphatase fusion proteins (scFv-AP/S). 
scFv expression Total number Number PLRV-reactive Percentage PLRV-reactive 
ScFv-Phage 
ScFv-c-Myc 
ScFv-AP/S 
48 
96 
48 
48 
0 
46 
100 
0 
95 
The advantages of pSKAP/S for the expression of antibody fragments were demonstrated 
with scFv selected against PLRV by antibody phage display technology (Table 4.1). ScFv from 
the fourth and fifth rounds of selection against antigen were expressed on the surface of phage 
and a high percentage reacted specifically with PLRV in phage-ELISA (Table 4.1). However, 
when scFv from this selection were expressed as soluble scFv-c-myc fusion proteins, no 
reaction with PLRV was obtained (Table 4.1). In contrast, when scFv from the fourth round of 
selection were recloned into pSKAP/S and expressed as scFv-alkaline phosphatase fusion 
proteins, a high proportion detected PLRV in ELISA (Table 4.1). 
Similar results were also obtained after overexpression of Ralstonia solanacearum 
specific scFv in pSKAP/S. Only four scFvs were isolated [5] on screening for scFv-c-myc 
fusion proteins binding to R. solanacearum, amongst which was the scFv designated anti-
LPS12. The same phage preparation used to isolate the soluble scFvs was then recloned into 
pSKAP/S, and a further ten different R. solanacearum-binding scFv were isolated (data not 
shown). In some clones scFv-AP/S fusion proteins were found mainly in the periplasm 
whereas others were mainly secreted into the culture fluid. This was determined by measuring 
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Figure 4.3. A) The scFv-AP/S proteins were purified using IMAC and the chromatogram is shown for 
the purification of anti-LPS7-AP/S (OD28o). The arrow indicates the starting point of the elution with 
imidazole and the background (imidazole only) is indicated by the dotted line. Collected fractions 
were assayed for AP activity (OD405) as indicated by the shaded area. B) The purified scFv-AP/S 
proteins were analyzed using SDS-PAGE and Coomassie brilliant blue staining: whole cell lysate anti-
LPS12-AP/S (lane 1), IMAC purified anti-LPS12-AP/S (lane 2), whole cell lysate anti-LPS7-AP/S 
(lane 3) and IMAC purified anti-LPS7-AP/S (lane 4). The arrow indicates the position of the scFv-
AP/S fusion-protein. 
the AP activity in the different cell extracts. The scFv-AP/S fusion proteins were purified from 
the osmotic shock fraction using MAC (Fig. 4.3A) and the apparent molecular mass was 
determined by SDS-PAGE (Fig. 4.3B). In the purified fraction, a major band of the expected 
75 kDa was present and a yield of approximately 2.5 mg per liter of culture was obtained. This 
was also true for the newly isolated scFv, LPS7-AP/S, which was seen to be partially 
degraded. Despite this partial degradation it showed improved association kinetics when 
comparable amounts of the scFv anti-LPS7-AP/S and anti-LPS12-AP/S fusion proteins were 
applied in Biacore analysis (Fig. 4.4). Anti-LPS12-AP/S fusion proteins dissociated more 
slowly from the LPS-matrix than anti-LPS7-AP/S fusion protein. The non-fused AP/S protein 
did not bind to LPS, and fusion proteins, like anti-LPS33-AP/S which had fast rate of 
dissociation, would probably not have been isolated without the use of the vector pSKAP/S. 
This emphasizes the need for optimal expression systems for soluble scFv. 
Figure 4.4. Biacore sensorgram of the scFv-
AP/S fusion proteins anti-LPS7-AP/S (A), anti-
LPS12-AP/S (O), anti-LPS33-AP/S (•) and 
AP/S (•). Binding of scFv-AP/S to 
lipopolysaccharides on the chip (association) 
was monitored for 200 s. Then buffer was 
applied to the chip and the release of the fusion 
proteins (dissociation) was observed for a 
further three minutes. 
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DISCUSSION 
The superiority of the pSKAP/S vector over previously described expression systems [12,13] 
was demonstrated by the overexpression of various scFv-AP/S fusion proteins, several of 
which could not be expressed as soluble scFv-c-myc fusion proteins. Moreover, convenient 
restriction sites allow the simple transfer of scFv genes from vectors commonly used in phage 
display like pHEN and the pCANTAB series [9,22,27]. Expression in pSKAP/S produced 
functional scFv-AP/S fusion proteins that were either secreted into the culture fluid or were 
retained in the periplasmic space. Screening of scFv-AP/S fusion proteins for antigen binding 
was possible by a simple ELISA without the need for additional enzyme-conjugated 
antibodies. 
In contrast to the commonly used IPTG-inducible lac promoter, the TetA promoter allows 
for induction of expression independently of the metabolic state of the bacteria. Even in the 
presence of high initial glucose concentrations, the Lac promoter becomes leaky due to 
glucose depletion at high cell densities, and the resultant heterologous gene expression causes 
toxicity and cell lysis prior to induction [24]. Levels of scFv-AP/S expression were found to be 
higher when the same scFv-AP/S sequence was expressed in the TetA promoter-based vector 
(pSKAP/S) compared to the lac promoter-based vector (pDAP2/S). Bacteria harboring 
pSKAP/S appear to suffer less from plasmid loss and showed no formation of satellite colonies 
on ampicillin-containing plates, or lysis of overnight cultures when grown at 37GC. Moreover, 
induction with aTc is an economical alternative to IPTG as it is used at low concentrations. 
When the Tet repressor gene was localized on the high copy expression vector pSKAP/S, the 
amount of 50-100 ng aTc per ml (Fig. 4.2A) was required for full induction of the TetA 
promoter. This, while only 20 ng aTc per ml was required in case the Tet repressor gene was 
localized on the E. coli chromosome [17]. Obviously, stronger repression is obtained when the 
Tet repressor gene is located on a high copy number plasmid than when it is integrated into the 
E. coli chromosome. However, there were no apparent adverse effects from the high levels of 
Tet repressor proteins, although they have been reported to be toxic when expressed at high 
levels. [17,25]. 
The vector pSKAP/S was shown to be a useful tool for the overexpression of scFv-AP/S 
fusion proteins. Also, it may usefully be applied to express other proteins that are toxic to E. 
coli, for example, restriction endonuclease CFr9\ [17]. Moreover, incorporation of the TetA 
promoter may be of general advantage in the construction of combinatorial antibody libraries 
because the TetA promoter/operator can be gradually induced over a wide range of aTc 
concentrations. Bacteria that produce toxic scFv have a growth disadvantage compared to 
bacteria expressing less toxic scFvs, and the former will tend to be outgrown. If measures are 
not taken to prevent expression of the scFvs, prior to rescue with helper phage, this may result 
in the desired antibodies being lost from the antibody pool. 
58 
From the selected scFv-AP/S fusion proteins produced in E. coli, several showed partial 
degradation when analyzed by SDS-PAGE, for example, LPS7-AP/S (Fig. 4.3B). Degradation 
is frequently observed on expression of foreign genes in E. coli and may be the result of the 
formation of inclusion bodies in the cytoplasm, or aggregates in the periplasm (both are known 
to induce the expression of proteases). It is possible that human antibody sequences may not be 
recognized efficiently by the folding machinery in E. coli cells. This may result in the improper 
folding of the scFv and the subsequent formation of inclusion bodies. The bacterial strains 
used for expression may be influential and indeed we observed higher levels of secretion with 
the XL 1-blue MRF' strain, as previously reported [2]. However, others have shown expression 
of Fab fragments to be independent of the bacterial strain [25]. Nevertheless, expression of 
scFv-AP/S fusion proteins with the aid of pSKAP/S in XLl-blue MRF' bacteria allowed 
several specific scFv to be isolated and characterized. These will now be further developed 
into higher affinity, stable immunoassay reagents, for example by site directed mutagenesis 
[21] or chain shuffling [19]. 
The correct folding of scFv has been shown to be dependent on the presence of some key 
amino acid residues [21,14]. In addition, Freund and co-workers [3] have shown the existence 
of an intermediate folding state between the correct and the misfolded states of scFv in the 
periplasm. Fusion of scFv to E. coli AP/S may cause the heterologous protein to be recognized 
by the chaperonins of E. coli, and furthermore, it may stabilize the scFv-AP/S fusion protein 
by shielding the hydrophobic residues on the surface of the scFv, thereby allowing a higher 
proportion of the expressed scFvs to fold properly. As the construction of all scFvs leads to the 
exposure of the residues of the former variable/constant domain interface, this strategy might 
lead to a generally applicable method for the expression of scFv fragments. 
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Chapter 5 
Application of phage display in selecting tomato spotted wilt 
virus-specific single-chain Fvs for sensitive diagnosis in ELISA 
ABSTRACT 
A panel of recombinant single-chain antibodies (scFvs) against structural proteins of tomato 
spotted wilt virus was retrieved from a human combinatorial scFv antibody library using the 
novel phage display technique. After subcloning the encoding DNA sequences in the 
expression vector pSKAP/S, which allowed the scFvs to be expressed as alkaline phosphatase 
fusion proteins, seventeen different scFv antibodies were obtained. Twelve of these scFvs 
were directed against the nucleoprotein (N) and five against the glycoproteins (G1/G2). Five 
of the N-specific antibodies cross-reacted with two other tospoviruses TCSV and GRSV, but 
none recognized the more distantly related tospoviruses INSV, WSMV, IYSV or PSMV. The 
successful use of one of the retrieved antibodies as coating and detection reagent in a double 
antibody sandwich ELISA showed the potential of the phage display system in obtaining 
antibodies for routine TSWV diagnosis. 
This chapter has been submitted in a modified form for publication: Griep, R.A., Prins, M., Van 
Twisk, C, Kerschbaumer, R.J., Kormelink, R., Goldbach, R.W. and Schots, A. Application of phage 
display in selecting tomato spotted wilt virus-specific single-chain Fvs for sensitive diagnosis in 
ELISA. 
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INTRODUCTION 
Tomato spotted wilt virus (TSWV), the representative of the Tospovirus genus within the 
family Bunyaviridae, is the causal agent [28] of a major viral disease in many crops. With an 
estimated annual crop loss of over one billion US $, TSWV ranks among the top-ten of most 
detrimental plant viruses worldwide [8,23]. The spread of this plant pathogen is difficult to 
control, for it has a wide host range of over 1000 plant species including mono- and 
dicotyledons of more than 80 different families. Tospoviruses are transmitted in a persistent 
manner by thrips, which over the recent years have become resistant against most applied 
insecticides. The spherical tospoviral particle (70-110 nm in diameter) contains three 
structural proteins: a 28 kDa nucleoprotein (N) which is tightly associated with three genomic 
RNA segments and two glycoproteins of 78 kDa (Gl) and 58 kDa (G2) which are associated 
with the viral envelope. Furthermore low amounts (10-20 copies per virion) of the viral 
polymerase (331 kDa) are present in the virus particle. 
Hardly any durable resistance genes against tospoviruses are available for conventional 
breeding purposes [23]. TSWV resistance has been obtained by transgenic expression of the 
nucleoprotein or movement protein (NSM) gene sequences of TSWV into tobacco [24] and 
tomato plants [33]. However, the use of transgenic plants for production of crops has been 
limited to date and epidemics of tospoviruses are still prevented by sanitary measures in 
combination with surveillance of disease development. Therefore, to prevent the spread of 
tospoviruses, diagnostic assays like ELISA or PCR have to be developed which are suitable 
for rapid detection of infected plants and, moreover, can be used for certification of plant 
propagation materials. 
High quality polyclonal antisera have been raised against several established members of 
the genus Tospovirus (Table 5.1) including TSWV [7], groundnut ringspot virus (GRSV) [5], 
impatiens necrotic spot virus (INSV) [20], tomato chlorotic spot virus (TCSV) [5] and 
watermelon silverleaf mottle virus (WSMV) [36]. They are now widely applied for tospovirus 
detection and with the aid of a double antibody sandwich (DAS)-ELISA [9, 35] they form a 
good compromise between sensitivity, ease and expense of application. However, the applied 
polyclonal antisera are generally based on N-specific antibodies and recognize mainly the 
species against which they were raised. Thus far, members of the genus Tospovirus have been 
classified into four distinct serogroups [1,6] (Table 5.1) which are a direct reflection of the 
sequence homologies (50-80%) of the N protein within the different tospovirus species [5]. 
The glycoproteins, on the other hand, are more conserved as they share common epitopes, and 
polyclonal antibodies raised against the glycoproteins of one virus species also detect others 
[2]. However, as the N protein is by far the most abundant viral protein in infected plants and 
tospoviruses moreover tend to lose their envelop during several passages in plants [25], this 
protein remains the target of interest for serological detection purposes. 
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Table 5.1. Members of the genus tospovirus used in this study. 
Species 
Tomato spotted wilt virus 
Tomato chlorotic spot virus 
Groundnut ringspot virus 
Impatiens necrotic spot virus 
Watermelon silverleaf mottle virus 
Iris yellow spot virus 
Physalis severe mottle virus 
Abbreviation 
TSWV 
TCSV 
GRSV 
INSV-NL 
INSV-US 
WSMV 
IYSV 
PSMV 
Sero-
group 
I 
II 
II 
III 
IV 
New 
New 
type 
I 
II 
Polyclonal antisera, although widely applied in routine diagnosis, are available in limited 
amounts and the specificity varies from batch to batch. Therefore, they are increasingly 
replaced by monoclonal antibodies (MAbs), as these are defined reagents that can be produced 
indefinitely [19]. In contrast to polyclonal antibodies, MAbs recognize single epitopes and 
may allow escape of viruses that lack those epitopes. To guarantee durable recognition of 
TSWV in the future, antibodies against conserved epitopes are required. Several MAbs have 
been raised against TSWV [1,16,26,29]. However, as new serogroups are still being 
established (Table 5.1), e.g. iris yellow spot virus (IYSV) [4] and physalis severe mottle virus 
(PSMV) [Kormelink, unpublished], there is a need for expansion of the available panel of 
MAbs that can be used for serological detection. 
Recombinant antibody technology in combination with the novel phage display 
technology [15, 22] (Fig. 1.5) provides an extremely useful approach for the production of 
target-specific antibodies [13,34]. Thus far, highly specific antibodies have already been 
obtained in this way against several important plant pathogens [11,12,14,30,37] without the 
use of laboratory animals and time-consuming immunization protocols. 
In this report we describe the use of the phage display technique to raise a broad panel of 
TSWV-specific recombinant antibodies from a human combinatorial antibody library [34]. 
Separate selections were carried out to retrieve recombinant scFvs against the major structural 
proteins of TSWV, i.e. the N protein and the Gl and G2 glycoproteins. As Gl and G2 form 
heterodimers that are hard to separate without introduction of a denaturating step, PhAbs were 
selected to either of these proteins. The scFv encoding genes retrieved were expressed in E. 
coli as ready to use antibody-enzyme fusion proteins [10] which were used for 
characterization of their reaction with TSWV and several other tospoviruses. In addition, one 
of the selected monoclonal scFvs was compared to a TSWV-specific polyclonal rabbit 
antiserum for its use as a coating and detecting reagent in a DAS-ELISA. 
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MATERIALS AND METHODS 
Bacterial strains 
E. coli strain TGI was used for the panning experiments. Expression of scFv-AP/S fusion 
proteins was performed in XLl-Blue MRF' Kan bacteria (Stratagene). 
Purification of tomato spotted wilt virus 
Infectious virus particles of TSWV Brazilian strain (BR-01) were isolated from systematically 
infected Nicotiana rustica var. America leaves according to Gonsalves and Trujillo [9]. 
Purified virions were finally collected from a 20-40% sucrose gradient, subsequently pelleted, 
resuspended in water and stored at -70°C. Concentration of viral protein was measured using 
the Biorad protein assay (Biorad). 
Purification of viral nucleocapsids 
Nicotiana rustica var. America plants were inoculated with TSWV (BR-01). After 8-18 days, 
systemically infected leaves were harvested and homogenized in 4 ml/g TAS-E buffer (freshly 
prepared: 0.1 M Tris-HCl; 0.01 M EDTA; 0.01 M Na2S03; 0.1% Cysteine, pH 8.0). The 
homogenate was filtered through 2 layers of cheesecloth and put on ice. The supernatant was 
centrifuged for 10 min at 3,000 rpm at 4°C in a GSA rotor, subsequently transferred to Ti45 
tubes and centrifuged a second time for 30 min at 20,000 rpm at 4°C in a Ti45 rotor. The 
pellet obtained, containing viral nucleocapsids, was resuspended in 0.4 ml/g TAS-R buffer 
(freshly prepared: 0.01 M Tris-HCl; 0.01 M EDTA; 0.01 M Na2S03; 0.1% Cysteine; 0.01 M 
Glycine; 1% Nonidet P40, pH 7.9) while gently stirring for 1-2 h at 4°C. A volume of 10 ml 
of the nucleocapsid material was enlarged to 30 ml using TAS-R buffer and layered on a 30 
ml 30% sucrose cushion (30% w/v sucrose in TAS-R buffer). After centrifuging for 2.5 h at 
28,000 rpm at 4°C in a Ti45 rotor, the supernatant was decanted, the nucleocapsid pellet 
resuspended overnight in PBS and stored at -70°C until further use. The concentration of N 
protein was measured using the Biorad protein assay. 
Preparation of virus-infected plant material for ELISA-assays 
Approximately 2 weeks after inoculation of Nicotiana benthamiana plants with tospoviruses 
GRSV (SA-05), INSV (US-01), INSV (NL-07), IYSV, PSMV, TCSV (BR-03), TSWV (BR-
01) or WMSV (Table 1), systemically infected leaves were harvested and homogenized 1:10 
w/v in extraction buffer (1 g leaf material/10 ml PBS 2% polyvinylpyrolidon) for use in 
ELISA. 
Selection of recombinant antibodies from a combinatorial antibody library 
Selection of target specific phage-antibodies (PhAbs, i.e. phages expressing functional scFv 
on their surface) from the human combinatorial antibody library [34] was performed 
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according to Griep and co-workers [12] with a few modifications. Immunosorbent tubes 
(Maxi-sorb, Nunc) were coated with either purified TSWV or with purified nucleocapsids, 
diluted in 50 mM Na2C03, pH 9.8 for 18 h at 4°C, according to Table 5.2. The derived PhAbs 
were stored at 4°C until use in the next panning round or in phage-ELISA. 
Table 5.2. The concentration of nucleocapsid (N) and complete tomato spotted wilt virus (TSWV) as 
was used for coating of immunosorbent tubes in combination with the number of washings applied 
during the panning procedure. 
Target Panning round Quantity (ug)a Washings 
Nucleocapsid 1 200 20 
2 200 20 
3 40 40 
4 4 40 
Intact virion 1 400 20 
2 200 20 
3 34 40 
4 4 40 
aTotal amount of target-antigen that was used for coating of the immunosorbent tubes. 
Subcloning of scFv encoding genes in expression vector pSKAP/S 
After the fourth round of selection the XL1 blue MRF' Kan bacteria were scraped from the 
plate and the scFv encoding phagemids were extracted using a plasmid DNA purification 
system (Wizard Midiprep, Promega). Phagemid DNA was digested [27] with HindUl and Notl 
and the excised scFv-encoding DNA fragments were gel-purified and subsequently ligated 
into HindJU/Notl digested pSKAP/S vector [10]. The ligation mix was transfected to E. coli 
XLl-blue MRF' Kan bacteria and the cells grown overnight at 37°C under selection pressure 
of 100 ug ampicillin (Amp) per ml LB agarose [27]. 
Production and purification of scFv-alkaline phosphatase fusion proteins 
Individual transformants were picked and grown overnight at 28°C in LB medium (100 ug 
Amp/ml). Prior to induction the bacteria were diluted 1:100 in 2TY medium (100 ug Amp/ml 
+ 2% glucose) and grown at 37°C. When the cultures had reached late log-phase (OD6oo of 
0.9) the temperature was decreased to 16°C for 1 h. Subsequently anhydrotetracycline (aTc) 
was added (0.2 ug/ml final concentration) and the bacteria were grown for an additional 18 h 
at 16°C. Bacterial cells were pelleted and resuspended in 1/20 volume (referring to the 
original culture volume) 50 mM Tris/HCl, pH 8 buffer containing 30% sucrose and 1 mM 
EDTA. After incubation for 5 min at 0°C, the scFv-alkaline phosphatase (scFv-AP/S) fusion 
proteins were extracted from the periplasm with 1/20 volume (referring to the original culture 
volume) of 5 mM MgS04 during 45 min at 0°C. In some cases the scFv-AP/S fusion proteins 
were further purified, using immobilized metal affinity chromatography (IMAC) according to 
Lindner and co-workers [21]. 
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Mval-fingerprinting 
To analyze the diversity of the recloned scFvs, restriction fragment length polymorphism 
(RFLP) fingerprinting was performed on PCR amplified scFv-DNA. Single colonies were 
picked and grown for 4 h in 2TY (100 (ig Amp/ml). From these suspensions, 2 ul was taken 
and added to a 48 ul PCR mix containing 2.5 uM dNTPs; 0.25 U Super Taq DNA polymerase 
(HT Biotechnology, Cambridge, UK); 10 uM pSK-forward (5'-ACT CTA TCA TTG ATA 
GAG TTA TTT TAC CAC TCC C-3') and 10 uM pSK-reverse (5'-TTT ATC GCT AAG 
AGA ATC ACG CAG AGC GGC G-3') primers; 2 mM MgCl2 and 50 mM Tris/HCl, pH 8. 
Amplification was performed in a thermal cycler (Perkin Elmer), 25 cycles (1 min 94°C; 2 
min 72°C) were performed. After PCR-amplification, 20 ul of the mix was digested with 10 U 
of restriction enzyme Mval (Boehringer) for 18 h at 37 °C. Digestion patterns were analyzed 
on a 3% FMC Metaphor agarose gel (Epicentre Technologies, Madison, USA). 
Phage-ELISA 
The phage-ELISA was essentially carried out according to Clark and Adams [3] and to Tijsen 
[32]. After each incubation step the microliter plates were washed 4 times with PBST (PBS 
containing 0.1% (v/v) Tween-20). In brief, ELISA plates (Labstar, Costar, Cambridge, UK) 
were coated overnight at 4°C with 100 ul/well purified viral nucleocapsids, diluted to 2 ug/ml 
in 0.1 M Na2C03/pH 9.8. Plates were blocked with 200 ul/well PBSTM-5% (PBST 
containing 5% skimmed milk) for 30 min at 37°C, washed twice with PBST and subsequently 
incubated for 1 h at RT with 100 ul phage sample dilutions, nucleoprotein-phage-antibody 
complexes were detected with monoclonal mouse-anti-M13 antibodies (MAb 12E4, 1 |ag/ml 
in PBSTM-2%), and finally with polyclonal rat-anti-mouse antibodies conjugated to alkaline 
phosphatase (Jackson Immuno-Research Laboratories, Inc., Westgrove, PA) diluted 1:2500 in 
PBSTM-2%. The ELISA was developed by adding 100 ul /?-nitrophenyl phosphate (p-NPP) 
substrate per well and scored for positive reactions by absorbance reading at 405 nm, usually 
within 60 min. 
Antigen coated plate ELISA 
An antigen-coated plate (ACP)-ELISA was used to assess the specificity of the recombinant 
scFv-antibodies, according to standard methods [3, 32], in which the plates were washed four 
times with PBST between each incubation step. In brief, ELISA plates were coated with either 
TSWV virions or with purified nucleocapsids, both diluted to 2 ug/ml in 0.1 M Na2C03. After 
blocking with PBSTM-5% for 30 min at 37°C, the plates were incubated for 1 h at 37°C with 
recombinant anti-TSWV scFv alkaline phosphatase fusion proteins, diluted 1:1 in PBTM-4% 
or with PcA-BROl-AP (alkaline phosphatase conjugated polyclonal Rabbit antibodies, raised 
against the nucleocapsid of TSWV), diluted 1:2000 in PBSTM-2%. The reactions were 
visualized by incubation with p-NPP substrate and optical densities were measured at 405 nm 
with an ELISA-reader. 
68 
Double antibody sandwich ELISA 
A double antibody sandwich (DAS)-ELISA was used to assess the reactions of the 
recombinant scFv-antibodies towards other tospoviruses. Between each incubation step the 
plates were washed four times with PBST. In brief, ELISA plates were coated (100 ul/well) 
for 18 h at 4°C with polyclonal antibodies, raised against the nucleocapsid of TSWV, TCSV, 
GRSV, INSV, IYSV or a mix of these, diluted 1:1,000 in 0.1 M Na2C03, pH 9.8. After 
blocking (200 ul/well) with PBSTM-5% for 30 min at 37°C, the plates were incubated with 
homogenates of either healthy or systemically infected N. benthamiana leaves. The plates 
were incubated with anti-TSWV scFv alkaline phosphatase conjugates, diluted 1:1 in PBTM-
4% (100 ul/well) for 1 h at 37°C. The reactions were visualized by incubation with p-NPP 
substrate and optical densities were measured at 405 nm with an ELISA-reader. 
Western blotting 
TSWV proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes. 
Reactive groups on the membrane were blocked with PBMT-5%. The reactivity of the scFv 
towards TSWV glycoproteins was shown by incubation of the Western blot with anti-TSWV 
scFv alkaline phosphatase conjugates and staining with BCIP/NBT substrate. 
RESULTS 
Selection of recombinant TSWV-specific antibodies 
In order to obtain scFv-antibodies directed against TSWV N protein or G1/G2 proteins, four 
successive rounds of selection (panning) were carried out against purified TSWV 
nucleocapsids or purified virions, respectively. While the amount of target antigen for coating 
was reduced and the washing was intensified during the panning procedure (Table 5.2), the 
recovery of phage-antibodies (PhAbs) from the immunosorbent tubes showed a strong 
increase for each subsequent round of selection (Fig. 5.1 A). After four rounds of selection, the 
specificity of the "polyclonal" PhAbs mixture, panned against the nucleocapsid, showed an 
increasing reactivity towards the nucleoprotein in phage-ELISA (Fig. 5.IB). 
Characterization of selected monoclonal scFv antibodies 
To allow efficient characterization of individual scFv producing clones, the obtained antibody 
encoding genes were recloned in expression vector pSKAP/S (Chapter 4, [10]) and expressed 
as scFv alkaline phosphatase fusion proteins. Upon screening in ACP-ELISA several clones 
were obtained producing monoclonal scFv-AP/S fusion proteins which bound to TSWV 
proteins. From the panning, carried out against purified TSWV virions, the obtained scFv-
AP/S fusion proteins reacted with complete TSWV particles only and not with purified 
nucleocapsids and are therefore specific to the glycoproteins. Other scFv-AP/S fusion 
proteins, all derived from the selection against purified nucleocapsids, reacted with complete 
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TSWV virions as well as with nucleocapsids and are thus directed against the N protein. 
Further analysis of the selected scFv encoding genes, using RFLP mapping with restriction 
enzyme Mval, revealed that five different G-specific monoclonal scFvs and 12 different N-
specific monoclonal scFvs were obtained. These were designated according to their target 
specificity and the number of the clone producing each particular scFv-AP/S fusion protein 
(Table 5.3). The diversity was confirmed by DNA-sequencing (data not shown). 
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Figure 5.1. Recovery and specificity of TSWV-binding phage-antibodies (PhAbs) in four sequential 
rounds of panning. PhAbs were applied to either TSWV virion- or N protein coated immunosorbent 
tubes and allowed to bind. Bound PhAbs were eluted after washing and used to infect E. coli. After 
phage rescue, with helper phage, the PhAbs (anti-TSWV enriched) were used for a new round of 
panning. A) The number of applied and recovered PhAbs was counted and the percentage recovery 
was plotted for each subsequent panning round. B) A phage-ELISA was performed with equal 
amounts of the selected anti-N-specific PhAbs and compared to comparable amounts of control 
PhAbs (derived from a panning against another antigen) to show that the binding was N-specific. 
Table 5.3. The obtained single-chain Fv-alkaline phosphatase fusion proteins were designated 
reflecting the target-antigen and the number of the first clone found with a unique Mval restriction 
pattern. 
Target-antigen 
Nucleoprotein 
(N) 
N3-AP/S 
N13-AP/S 
N19-AP/S 
N25-AP/S 
N28-AP/S 
N32-AP/S 
N35-AP/S 
N40-AP/S 
N54-AP/S 
N56-AP/S 
N63-AP/S 
N97-AP/S 
Glycoproteins 
(G1/G2) 
G118-AP/S 
G150-AP/S 
G180-AP/S 
G220-AP/S 
G224-AP/S 
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Differences in the expression levels were found for the obtained scFv-AP/S fusion proteins. 
The production in E. coli of functional scFv-enzyme fusion proteins varied from less than 50 
ug/L of bacterial culture for the scFv-AP/S fusion-protein of N32, to 4 mg /L for Gl 18-AP/S. 
All glycoprotein-specific fusion proteins (Table 5.3) reacted in ACP-ELISA with purified 
TSWV virions. The osmotic shock fraction of Gl 18-AP/S (4 mg/ml) even gave a positive 
signal when diluted up to 10,000 times (Fig. 5.2). However, when homogenates of TSWV-
infected N. benthamiana leaves were used for coating in an ACP-ELISA format, only weak 
reactions were obtained with all G-specific scFv-AP/S fusion proteins. In Western blot 
analyses, G150-AP/S could be identified as G2-specific and G224-AP/S as Gl-specific (data 
not shown), whereas for the remaining G-binding antibodies the specificity could not be 
determined as their epitopes were denatured by SDS-treatment. 
Q 
O 
2 
1.5 
1 
0.5 
n 
°V 
v. 
"~^n • 
- • - AP/S 
- o - G118-AP/S 
- A - G150-AP/S 
- v - G220-AP/S 
- a - G224-AP/S 
• I M ^ ^ Q - . m 
Figure 5.2. Reaction of glycoprotein 
(Gl/G2)-specific single-chain (scFv) alkaline 
phosphatase (AP/S) fusion proteins in antigen-
coated plate ELISA. The G-specific scFv-
AP/S fusion proteins were extracted from the 
periplasm of clones G118, G150, G220 and 
G224 and applied in serial dilutions into wells 
of an ELISA-plate coated with TSVW virions. 
AP/S without a scFv served as a negative 
control. 
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Reactivity of TSWV-specific scFvs towards other tospoviruses 
In order to analyze whether the selected recombinant antibodies also recognized other 
tospovirus species besides TSWV, they were tested using homogenates of N. benthamiana 
leaves systematically infected with GRSV, INSV, IYSV, PSMV, TCSV, TSWV or WMSV 
(Table 5.1). While in an ACP-ELISA no significant reactions were obtained, except for the 
homologous reaction with TSWV, positive reactions (Fig. 5.3) were observed when aliquots 
of TCSV-infected plant extract were blotted onto nitrocellulose and N3-AP/S, N19-AP/S and 
N56-AP/S were used for detection. In addition, the Gl-reactive fusion protein, G224-AP/S 
also reacted in this dot-blot assay, but only with TSWV (data not shown). 
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fragment alkaline phosphatase fusion proteins 
in a dot-immunobinding assay to other 
tospovirus species. 
71 
Table 5.4. Results of double antibody sandwich ELISA in which the plates were coated with a 
polyclonal TSWV N antiserum. Samples containing complete virions (CV), nucleoprotein (N) or 
buffer (B) were applied and the binding of the various N-specific scFv-AP/S fusion proteins was 
visualized using p-nitrophenyl phosphate substrate. 
Clone 
AP/S 
3 
13 
19 
25 
28 
32 
35 
40 
54 
56 
63 
97 
OD405 
CV 
0.03 
1.17 
0.14 
1.01 
0.06 
0.13 
0.04 
0.20 
0.05 
0.53 
0.81 
0.15 
0.08 
after 2 hours substrate 
incubation3 
N 
0.03 
1.22 
0.18 
0.96 
0.07 
0.18 
0.05 
0.55 
0.07 
0.45 
0.97 
0.18 
0.13 
B 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.04 
0.03 
0.03 
0.03 
0.03 
OD 4 0 5 
CV 
0.05 
>3 
2.70 
>3 
1.16 
2.58 
0.43 
>3 
0.77 
>3 
>3 
2.65 
1.58 
after 18 hours substrate 
incubationa 
N 
0.05 
>3 
>3 
>3 
1.6 
2.80 
0.55 
>3 
1.14 
>3 
>3 
2.80 
2.45 
B 
0.05 
0.05 
0.04 
0.05 
0.04 
0.12 
0.04 
0.06 
0.18 
0.03 
0.04 
0.04 
0.05 
aThe data were obtained from a representative experiment and the standard deviations (n=2) were 
smaller than 0.1 for all presented data. 
Table 5.5. Results of double antibody sandwich ELISA in which the plates were coated with specific 
antisera against TSWV N, 1NSV N, TCSV N or GRSV N proteins. Plant extracts containing the 
homologous tospoviral nucleoprotein were applied and the binding of the scFv-AP/S fusion proteins 
was visualized. 
Clone 
AP/S 
3 
13 
19 
25 
28 
32 
35 
40 
54 
56 
63 
97 
OD405 after 2 hours substrate 
PE + 
TSWV 
0.03c 
1.82 
0.38 
1.30 
0.15 
0.37 
0.05 
0.81 
0.12 
1.11 
1.23 
0.33 
0.22 
incubation3 
PE + 
TCSV 
0.03 
0.14 
0.03 
0.12 
0.03 
0.04 
0.03 
0.03 
0.03 
0.03 
0.12 
0.03 
0.05 
PE + 
GRSV 
0.03 
0.04 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.04 
0.03 
0.03 
0.03 
0.04 
PE + 
HVSV 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.03 
0.04 
0.03 
0.03 
0.03 
0.03 
OD405 after 18 hours substrate 
PE + 
TSWV 
0.06 
>3 
>3 
>3 
2.71 
>3 
0.73 
>3 
2.15 
>3 
>3 
>3 
>3 
incubation3 
PE + 
TCSV 
0.07 
2.51 
0.16 
2.41 
0.56 
0.15 
0.05 
0.08 
0.07 
0.12 
2.41 
0.06 
0.81 
PE + 
GRSV 
0.06 
0.30 
0.09 
0.25 
0.12 
0.06 
0.04 
0.08 
0.07 
0.13 
0.36 
0.11 
0.25 
PE + 
INSV 
0.05 
0.06 
0.05 
0.06 
0.04 
0.06 
0.05 
0.06 
0.06 
0.12 
0.05 
0.05 
0.05 
PE 
0.05 
0.05 
0.12 
0.05 
0.04 
0.12 
0.04 
0.06 
0.18 
0.18 
0.04 
0.04 
0.05 
3The data were obtained from a representative experiment and the standard deviations (n=2) were 
smaller than 0.1 for all presented data. 
72 
In order to determine whether the different results obtained were due to the (ACP-) 
ELISA format, a DAS-ELISA was performed on TSWV-infected leaf material. To this end, 
ELISA plates were coated with TSWV-specific polyclonal anti-N serum. Samples of TSWV-
infected leaf material, purified TSWV nucleocapsids or TSWV virions were applied and 
tested for recognition. Results with N-specific scFv-AP/S fusion proteins showed a clear 
reaction in almost all cases with TSWV containing samples (Table 5.4), although some 
reactions, e.g. N40-AP/S, showed a lower OD405 absorbance, probably due to a lower affinity 
of this scFv-AP/S protein for the nucleocapsid. The reaction was N-specific, as no reaction 
above the background was obtained with buffer or when non-conjugated AP/S or G-specific 
scFv-AP/S fusion proteins were applied. 
In analogy to this, a DAS-ELISA was performed in which the plate was coated with each 
of the N-specific antisera that were raised against the nucleocapsids of six different 
tospoviruses (Table 5.1). The results from this ELISA (Table 5.5) showed clear reactions with 
TCSV and GRSV in combination with N3-AP/S, N19-AP/S, N25-AP/S, N56-AP/S and N97-
AP/S, although less intensive compared to TSWV. No reactions were observed with any of 
the more distantly related species INSV, IYSV, PSMV and WMSV. 
From the latter results, combined with those obtained in the ACP-ELISA, it is clear that the 
fusion proteins N3-AP/S, N19-AP/S, N25-AP/S, N56-AP/S and N97-AP/S do show 
recognition of TSWV, TCSV and GRSV in a DAS-ELISA format but not in ACP-ELISA 
format. Moreover, whereas GRSV is not recognized in the ACP-ELISA or on dot-blot, this 
virus is recognized at low efficiency with the aforementioned scFv-AP/S fusion proteins in 
DAS-ELISA. 
Sensitivity in TSWV diagnosis 
To test the potential of the derived monoclonal scFv antibodies the "broad-reacting" N56-
AP/S fusion protein, able to recognize serogroup I & II species, was purified and further 
characterized for its applicability in TSWV diagnosis. Different amounts of TSWV-derived 
nucleocapsids were diluted into healthy plant extracts of N. benthamiana and tested in a DAS-
ELISA (Table 5.6). At a concentration of 0.1 ug N56-AP/S per ml the detection limit obtained 
for the N protein was comparable to the detection limit obtained using the polyclonal antibody 
alkaline phosphatase conjugate at 0.5 ug per ml. This resemblance in sensitivity was also 
observed when serial dilutions of healthy and TSWV-infected N. benthamiana homogenates 
were screened in a DAS-ELISA. Whereas samples are tested in routine diagnosis at dilutions 
of 10-100 times, both the scFv-AP/S fusion-protein of N56 (Fig. 5.4A) and the polyclonal 
antiserum (Fig. 5.4B) detected TSWV in extracts of N. benthamiana at dilutions up to 
1:16,000. 
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Figure 5.4. A) Determination of double antibody sandwich ELISA detection limit for nucleocapsid 
protein (N) in TSWV-infected plant extract as assayed A) with the single chain variable fragment 
antibody alkaline phosphatase fusion-protein N56-AP/S or B) with a TSWV N-specific polyclonal 
antiserum conjugated to alkaline phosphatase. The wells of an ELISA plate, coated with a TSWV N-
protein specific polyclonal antiserum, were incubated with extracts of healthy Nicotiana benthamiana 
plants (PE) or TSWV-infected N. benthamiana plants (PE-TSWV). Serial dilutions, of PE and PE-
TSWV, were made either in PE or in PBS containing 2% skimmed milk powder and 0.1% Tween-20 
(PBTM-2%). The N-specific polyclonal antiserum AP conjugate was applied at 0.5 |ig/ml and the 
fusion-protein N56-AP/S at 0.1 ug/ml. 
Table 5.6. Determination of the detection level for the nucleocapsids of tomato spotted wilt virus 
using a double antibody sandwich ELISA in which the plates were coated with specific antisera 
against TSWV nucleocapsids. Compared were the nucleoprotein-specific single-chain N56 fused to 
alkaline phosphatase (AP/S) and the conventional alkaline phosphatase (AP) conjugated TSWV N-
specific polyclonal antibodies. Purified nucleocapsids were diluted in a healthy plant extract (PE). 
Antibody-enzyme conjugate 
nucleocapsids (ng/ml) N56-AP/S (0.1 |ig/ml)a Polyclonal-AP (0.5 ng/ml)b 
1000 
500 
100 
50 
10 
5 
1 
PE 
2.31 ±0,102 
1.98 ±0,053 
0.77 ± 0,053 
0.40 ± 0,057 
0.14 ±0,005 
0.08 ± 0,002 
0.06 ± 0,004 
0.05 ± 0.01 
2.89 ±0,015 
2.51 ±0,049 
1.16 ±0,087 
0.77 ±0,041 
0.32 + 0,026 
0.21 ±0,030 
0.17 ±0,004 
0.14 ±0,03 
aELISA-readings after 2 h incubation with p-nitrophenyl phosphate substrate at room temperature + 
16 h at 4 C. 
"ELIS A-readings after 2 h incubation with p-nitrophenyl phosphate substrate at room temperature 
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Figure 5.5. A) The alkaline phosphatase gene of N56-AP/S was replaced by the constant Kappa light 
chain domain (CL) and a leucine zipper domain (ZIP). Transformed bacteria produce fusion proteins 
of scFv N56 and the CLZIP domains upon induction. The CLZIP-N56 fusion proteins are secreted 
into the periplasm where they dimerize. B) The CLZFP-N56 fusion proteins can be used for coating 
the wells of an ELISA plate that is subsequently incubated with extracts of TSWV-infected N. 
benthamiana plants (PE-TSWV). For detection of captured nucleocapsids (N) an N-specific scFv 
alkaline phosphatase fusion protein can be applied (scFv-AP/S). 
Development of a complete recombinant DAS-ELISA 
While a DAS-ELISA utilizing the TSWV/N-specific polyclonal antiserum as coating reagent 
and the N56-AP/S fusion protein for detection was highly sensitive for TSWV (Fig. 5.4A), the 
use of scFv N56 as coating reagent was also evaluated. As scFvs are inactivated upon coating 
to ELISA-plates [17], a construct of scFv N56 was assembled (Fig. 5.5A) in which the AP/S 
encoding gene was replaced by a sequence encoding the constant domain of the mouse light-
chain (CL), a leucine zipper (ZIP) dimerization domain and a His(6)-tag [18], The expressed 
N56-CLZIP protein was purified by M A C and compared to the polyclonal TSWV/N-specific 
antiserum for coating efficiency utilizing a DAS-ELISA (Fig. 5.5B). At a coating density of 1 
ug/ml the N56-CLZIP fusion protein was equally effective (Table 5.7), which demonstrates 
that TSWV can be efficiently detected with a DAS-ELISA that is entirely based on 
recombinant MAbs. 
Table 5.7. Comparison of coating and detection efficiency using a combination of conventional 
TSWV/N specific polyclonal antibodies or recombinant antibodies in a double antibody sandwich 
ELISA. Healthy plant extract (PE) or TSWV-infected plant extract (PE-TSWV) was applied at 1 g per 
20 per ml of extraction buffer. 
Detection reagent 
Coating reagent 
PAb-TSWV-AP 
(0.5 ug/ml) 
N56-AP/S 
(0.1 ug/ml) 
N56-AP/S 
(1 Ug/ml) 
PEa PE-
TSWV0 
PE* PE-
TSWV0 
PEa PE-
TSWV0 
PAb-TSWV N (0.5 ug/ml) 
CLZff-56 (0.1 ug/ml) 
CLZIP-56 (1 ug/ml) 
0.04 
0.04 
0.04 
0.99 
0.51 
0.73 
0.03 
0.03 
0.05 
0.57 
0.36 
0.71 
0.05 
0.05 
0.05 
1.39 
0.71 
1.28 
aStandard deviations obtained with healthy plant extract (PE) were smaller than 0.006 
DStandard deviations obtained with TSWV-infected plant extract (PE) were smaller than 0.1 
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DISCUSSION 
With the aid of the phage display system, a series of 17 different TSWV-specific scFvs was 
retrieved from the Vaughan combinatorial scFv-antibody library [34], utilizing expression as 
scFv-alkaline phosphatase fusion protein in E. coli. Twelve of these scFv-AP/S fusion 
proteins were identified as N-specific and five were directed against the glycoproteins of 
TSWV (Table 5.3). 
From the series of N-specific scFv-AP/S fusion proteins, N56-AP/S, at a concentration of 
0.1 ug/ml could detect as little as 1 ng (Table 5.6) of N protein in a DAS-ELISA. In addition it 
was shown that the CLZTP fusion protein of scFv N56 can be used as an effective coating 
reagent (Table 5.7), suggesting that this recombinant scFv represents a promising candidate 
for development of a complete recombinant diagnostic assay for routine detection of TSWV 
in plant material. 
Extensive ELISA and Western immunoblot analyses have demonstrated that the obtained 
antibodies recognized at least five epitopes of the three structural TSWV proteins. Fusion 
proteins G150-AP/S and G224-AP/S were found to recognize continuous epitopes on G2 or 
Gl, respectively, whereas G118-AP/S most likely recognized a discontinuous epitope, as 
reactivity was absent after mild denaturation of the glycoproteins by SDS-treatment. From the 
N-specific scFv-AP/S, some reacted with the N-protein of TSWV, whereas others reacted 
with an epitope that was not only present on the N-protein of TSWV, but also on those of 
TCSV and GRSV. The N encoding genes of the latter isolates have been sequenced and share 
around 78% sequence identity [5], but thus far, no scFvs have been observed recognizing a 
common epitope within the N protein of all different tospovirus species. N56-AP/S is one of 
few selected MAbs that recognizes up to three different tospoviruses, i.e. TSWV, GRSV and 
TCSV, and must therefore be directed against a common epitope. 
Polyclonal TSWV N-specific antisera, and now also some scFv, have been shown to 
cross-react with TCSV and GRSV isolates. For a universal tospovirus diagnosis system a scFv 
is required that recognizes all tospoviruses, even those that currently still escape from 
detection. However, instead of searching for one single universal scFv, it is recommended to 
pool a set of broad-reacting MAbs and thus to obtain a specific "polyclonal antiserum" with a 
defined character and with continuous specificity for all the species within the genus 
Tospovirus. 
The data presented in this report have demonstrated the feasibility of the phage display 
technique to select a large panel of TSWV-specific MAbs and is in strong support for the 
identification of new series of scFv-antibodies. Some of which likely will have a broader 
tospoviral detection range. As the phage display technique allows to alternate selections 
between N (or G1/G2) proteins obtained from different isolates, it may now be possible to 
guide selection of MAbs towards shared epitopes. After all, selection of MAbs by phage 
display is not biased to a certain epitope on basis of immunogenicity but merely by the 
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frequency of occurrence. This means that selection would be for specificity against the most 
prominent conserved epitopes within the N (or G1/G2) proteins. 
Since the tospoviral N protein is involved in many viral processes, such as packaging of 
RNA, replication, movement and transmission, an antibody that disrupts epitopes involved in 
one of these processes may be successful in conferring resistance upon expression in plants. 
The principle of such "plantibody"-mediated resistance has been shown with a recombinant 
MAb against artichoke crinkled mottle virus by Tavladoraki and co-workers [31]. As the 
genes encoding the TSWV-specific scFv-antibodies were obtained using the phage display 
technique, they can be readily transferred into plants. Moreover, if later on mutants of TSWV 
evolve which potentially could overcome the antibody-mediated resistance, new inhibiting 
antibodies can be raised to ensure durable resistance, and in addition, to safeguard detection in 
plants. After all, the power of the phage display system is the selection of large panels of 
target-specific scFvs from naive combinatorial libraries, as was shown in this report in the 
case of TSWV. 
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Chapter 6 
Fluobodies: 
green fluorescent single-chain Fv fusion proteins 
ABSTRACT 
Expression of single-chain Fv antibodies and green fluorescent protein as fusion proteins 
(fluobodies) in Escherichia coli could facilitate the diagnosis of various diseases in single step 
assays based upon immunofluorescence and/or flow-cytometry. They might even replace 
some reagents frequently used in immunology such as chemically produced antibody-
fluorochrome conjugates. Therefore, an expression system (pSKGFP) was designed that 
allows the expression of single-chain variable fragments as fusion proteins with modified 
green fluorescent proteins. The resulting green fluorescent single-chain Fv fusion proteins can 
be produced by expression in E. coli and purified in a single step via metal affinity 
chromatography. Two different single-chain variable fragment antibodies, both directed 
against the lipopolysaccharide of the bacterium Ralstonia solanacearum have been genetically 
fused to a red-shifted green fluorescent protein and the produced fusion protein was tested for 
usefulness in flow-cytometry and immunofluorescent cell staining. The fluobodies could be 
produced in cultures of bacterial cells and purified using immobilized metal affinity 
chromatography. They work well in flow-cytometry and immunofluorescent cell staining, are 
specific for their target antigens and unlike FTTC-conjugated antibodies they do not fade upon 
illumination. The expression system is compatible to frequently used phage display vectors. 
Genes encoding single-chain antibody fragments can be easily transferred from these vectors 
into pSKGFP that allows single-step characterization of the selected recombinant antibodies 
by flow-cytometry or fluorescent cell staining. 
This chapter has been submitted for publication in a modified form: Griep, R.A., van Twisk, C, van 
der Wolf, J.M. and Schots A. Fluobodies: green fluorescent single-chain Fv fusion proteins. 
INTRODUCTION 
Immunofluorescence (EF) [8,24] and phenotyping by flow-cytometry are useful techniques for 
localization studies or for the diagnosis of various diseases [18,23]. The fluorochrome 
fluorescein isothiocyanate (FITC) has been used extensively for this purpose. However, this 
fluorochrome is very sensitive to photobleaching by illumination. Moreover, conjugation to 
antibodies is not reproducible and if it occurs within the antigen binding site partial or 
complete loss of the antigen binding capacity might occur [23]. After all, lysine, the 
conjugation target for FITC is found frequently within antigen-binding sites [16]. Therefore, 
new alternative fluorochromes with comparable excitation and emission spectra but lacking 
the disadvantages of FITC have to be explored. 
The green fluorescent protein (GFP) from the jellyfish, Aequorea victoria, was recently 
described [3,14,22] and is a promising fluorescent probe with an emission peak at the same 
wavelength as FITC (510 nm). The wild-type GFP has two excitation peaks, a major one at 
395 nm and a minor at 470 nm [32]. It was found to be very stable when excited at 480 nm 
[19,31]. Mutagenesis of wild-type GFP [4,5,6,10] led to improved versions of GFP. One of 
these mutants, GFPuv, had an increased expression level of GFP in bacteria and better 
solubility of the produced protein. Another mutant, GFPmutl [4], had one single red-shifted 
excitation peak at 488 nm and contained two amino acid substitutions (PheM to Leu and Ser65 
to Thr). It was found to fluoresce 35-fold more intensely than the wt-GFP when excited at 488 
nm. Therefore, with the fluorochrome characteristics of FITC and an increased stability, this 
GFPmutl spectral variant seems suited for application in IF and flow-cytometry. 
Genetic fusion between antibody and GFP encoding genes would be ideal. It gives a 1:1 
ratio between antibody and fluorochrome without the chance of inactivation. Recent progress 
in molecular immunology [9,13,21,26,30] has allowed cloning and expression of antibody 
encoding genes in E. coli. In this study, we describe the genetic fusion of the red-shifted 
(mutl) mutant of GFP to two recombinant, Ralstonia solanacearum (biovar 2, race 3) 
specific, single-chain variable fragment (scFv) antibodies [7,8] and the overexpression in E. 
coli. The use of these fluobodies was evaluated in IF and flow-cytometry. 
MATERIAL AND METHODS 
Mutating, cloning and production of a red shifted green fluorescent protein 
To change the excitation peak of wild-type GFP or GFPuv (Clontech) from 396 nm to 488 nm 
[4], two amino acid changes were introduced by PCR (Fig. 6.1). Phe64 was replaced by Leu 
and Ser65 by Thr. 
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Figure 6.1. Simultaneous addition of restriction sites to, and side directed mutagenesis within the 
wild-type GFP DNA sequence by the polymerase chain reaction (PCR). Mutations (spheres) and 
restriction sites (boxes) are incorporated during 2 separate PCR steps, which yield the amplified DNA 
fragments GFP-A and GFP-B. As these fragments have overlapping DNA sequences, they can anneal 
and the complementary strands will be made by the DNA polymerase (PCR-3). However, within the 
transformed bacterium it is dependent on DNA mismatch repair whether or not a mutation is 
maintained. As the primers GFPI and GFPNco were degenerate on the positions encoding for the 
cysteine residues, these mutations will only be present in a small fraction of the GFP transformants. 
Briefly, from an E. coli culture, containing the GFP gene, 5 jul was taken and added to a 
95 ill PCR mix containing 2.5 nM dNTPs; 0.25 U Super-Taq DNA polymerase (HT 
Biotechnology, Cambridge, UK); 2 mM MgCl2 and 250 nM of either the primer combination 
GFP52 (5'-TTT TTA AGC TTC GCC ATG GCC GCG GCC GCA AGT AAA GGA GAA 
GAA CTT-3') and GfpNco (5'-TCT TGA AAA GCN CTG AAC ACC ATA AGT CAG 
AGT AGT GAC A AG TGT TGG CCA CGG AAC AGG-3') or primer combination GFPI 
(5'-CTT ACC CTT AAA TTT ATT AGC ACT ACT G-3') and GFP32 (5'-GCT AGC GAA 
TTC CCT AGG TCA GTG ATG GTG ATG ATG GTG TTT GTA TAG TTC ATC CAT-3') 
in 50 mM Tris/HCl, pH 8. The PCR amplification (27 cycles: 1 min 94°C; 3 min 72°C, 1 min 
40°C) was carried out in a thermal cycler (Perkin Elmer) and the PCR products, GFP-A 
(obtained with GFP52 x GFPNco) and GFP-B (obtained with GFPI x GFP32) were gel-
purified (Easyprep, Pharmacia, Uppsala, Sweden). From the purified fragments, GFP-A and 
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GFP-B, 2.5 ul was added to 95 ul PCR mix containing 2.5 uM dNTPs; 0.25 U Super-Taq 
DNA polymerase; 2 mM MgCl2 in 50 mM Tris/HCl, pH 8. PCR cycling was carried out, 
without primers, for 10 cycles to allow the fragments to be joined by splicing by overlap 
extension [12]. 
To allow amplification of the mutated GFP genes, 20 additional cycles were carried out 
after addition of the outer primers GFP52 and GFP32. The obtained PCR products were 
digested after phenol extraction and ethanol precipitation, with HinDlII and EcoRI. This was 
followed by ligation into HinDHVEcoRl digested pUC119 vector DNA. After transfection, 
the E. coli bacteria (XLl-Blue-MRF' Kan, Stratagene) were plated on selective LB-plates 
(100 |ig Amp/ml) and grown overnight at 37°C. 
Bacteria were screened for the presence of red-shifted GFPmutl or GFPuv/mutl mutants 
(Leu64 and Thr65) by illumination with UV-light (395 nm) or light of 488 nm. Colonies which 
showed bright green fluorescence only when illuminated at 488 nm were picked, streaked and 
cultured in 100 ml of 2TY (containing 100 ug Amp/ml and 0.05 % glucose) at 37°C. When 
the OD^ reached 0.5, the temperature was decreased to 16°C. After 16 h, the bacteria were 
pelleted, the supernatant discarded and the bacteria were resuspended in 2TY medium 
(containing 100 ug AMP/ml) and grown for two additional days at 16°C. 
The bacteria were pelleted and resuspended in 2 ml PBS + 0.1% Tween-20 to isolate the 
produced GFPmutl or GFPuv/mutl protein. The bacteria were lysed by repeated (5X) 
freezing and thawing [15]. The bacterial debris was removed by centrifugation and the 
supernatants were analysed for the presence of GFPmutl protein by measuring the spectral 
properties with aid of a fluorometer. The produced (His)6-tagged GFP proteins were purified 
from the periplasmic fraction with immobilised metal affinity chromatography (IMAC) using 
Ni-NDA beads (Pharmacia, Uppsala, Sweden). Bound GFP or GFPuv/mutl proteins were 
eluted with 0.1 M Tris/pH 8 containing 100 mM EDTA and stored at -20°C until use. 
Production of scFv-GFP fusion proteins (fluobodies) 
The improved GFP encoding sequences were digested out of the vector pUC119-GFPmutl 
(Fig. 6.2A) with Notl and £coRI, gel-purified and ligated into NotVEcoRl digested pSKAP/S 
vector DNA [7], in frame with the scFvs anti-LPS12 [8] or anti-LPS7 [7]. The resulting vector 
pSK-GFPmutl (Fig. 6.2B) was transfected to E. coli bacteria (XLl-Blue-MRF' Kan, 
Stratagene). Transformed bacteria were plated on selective LB-plates (100 ug Amp/ml) and 
grown overnight at 25°C. Individual colonies were tooth-picked and grown in 0.75 ml of LB-
broth (100 ug Amp/ml) in 48 well plates (250 rpm). When the OD6IK) reached 0.5, the 
temperature was decreased to 16°C. After 1 h anhydrotetracycline was added to the medium 
(0.2 ug/ml final concentration) and growth was prolonged. After 48 h samples were taken and 
the fluorescence at 488 nm was measured with a fluorometer (Perkin Elmer 7700). 
84 
GFPmutl HIS-tag pUC119-vector 
.pUC119-vector / GFP 
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Figure 6.2. A) Schematic representation of the vector pUC119-GFPmutl. The positions of the LacZ 
promoter, the ribosomal binding site (RBS), the GFPmutl sequence and the His(6)-tag are indicated. 
Within the nucleotide sequence, the important restriction sites are underlined and the nucleotides that 
differ from the wild-type sequence are in bold face. The start codon of translation is indicated by the 
horizontal arrow and the termination-codon by TER. Numbering of amino acids is according to the 
wild-type GFP protein sequence. B) Schematic representation of the vector pSK-GFPmutl. The 
position of the Tet promoter (inducible with anhydrotetracycline), the RBS, the chloramphenicol 
acetyltransferase leader sequence (CAT), the single-chain Fv (scFv), the GFPmutl sequence and the 
His(6)-tag are indicated. The important restriction sites are underlined, and within the nucleotide 
sequence the nucleotides that differ from the wild-type sequence are in bold face. The start-codon for 
translation is indicated by the horizontal arrow and the termination codon by TER. Numbering of 
amino acids is according to the wild-type GFP protein sequence. The site were the CAT-signal 
peptide is cleaved from the scFv-GFP fusion protein is indicated by the vertical arrow. 
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Purification of fluobodies 
Cultures were grown, induced and pelleted as described above. After incubation (5 min, 0°C) 
of the bacteria with 1/20 volume (referring to the original culture size) of a 50 mM Tris/HCl 
pH 8 buffer containing, 30% sucrose and 1 mM EDTA, the produced proteins were extracted 
(45 min, 0°C) from the periplasm with 1/20 volume of 5 mM MgS04. The produced (His)6-
tagged proteins were purified from the periplasmic fraction with immobilized metal affinity 
chromatography (MAC) using Ni-NDA beads (Pharmacia, Uppsala, Sweden). Bound 
proteins were eluted with 0.1 M Tris/pH 8 containing 100 mM EDTA and stored at 4°C. 
SDS-PAGE and Western blotting 
Purified GFP and fluobodies were loaded on a 12.5 % SDS polyacryl amide gel and blotted 
onto nitro-cellulose according to Towbin and co-workers [27]. After blocking for 30 min with 
PBS (containing 5% skimmed milk powder and 0.1 % Tween-20) the Western blot was 
incubated (1.5 h, room temperature) with GFP specific polyclonal rabbit antibodies (Clontech) 
diluted 1:25,000 in PBS (containing 2% skimmed milk powder and 0.1 % Tween-20). After 
washing (4 x, PBS 0.1 % Tween-20) the blot was incubated for 1 h with alkaline phosphatase 
conjugated Goat anti-Rabbit polyclonal antibodies (diluted 1:5,000 in PBS containing 2% 
skimmed milk powder and 0.1 % Tween-20). Finally, staining with 5-bromo-4-chloro-3-
indoylphosphate/nitroblue tetrazolium substrate (BCIP/NBT) was used to visualize the bands 
on the Western blot. 
Flow-cytometry 
Purified GFPmutl or scFv LPS12-GFPmutl fluobodies were added to suspensions of 
Ralstonia solanacearum or Ralstonia picketii (107 bacteria/ml PBS, containing 0.1% Tween-
20 and 5% FCS) and incubated for 1 h while rotating. Bacteria were washed twice with PBS + 
0.1 Tween-20, resuspended in 1.5 ml PBS and analyzed for fluorescent staining. From each 
sample 10,000 bacteria were screened, using a fluorescent activated cell sorter. 
Immunofluorescence 
IF was performed according to Van der Wolf and co-workers [29]. For IF cell-staining the 
bacteria were coated on microscope slides and incubated with GFPmutl, scFv LPS7-
GFPmutl fluobodies or with a R. solanacearum-specific FITC-conjugated polyclonal rabbit 
antiserum. 
DNA Sequencing 
The nucleotide sequences of the GFP inserts in pUC119 were verified by the dideoxy chain 
termination method [25] on an A.L.F. DNA sequencer (Pharmacia). 
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RESULTS 
The Aequorea wt-GFP gene was modified by PCR to generate the GFPmutl spectral mutant 
with a single excitation peak at 488 nm. In addition, a his-tag was added to the C-terminus of 
the GFP protein and convenient restriction sites for cloning into the pUC119 vector were 
added. Moreover, an attempt was carried out to change the cysteine residues on positions 48 
and 70 by PCR, as it was anticipated these that would interfere with secretion of functional 
scFv-GFP fusion proteins into the periplasmic space. 
Several bacteria obtained from transfection of the pUC119-GFPmutl vector DNA (Fig. 
6.2A) showed fluorescence only when illuminated at 488 nm (i.e. production of red-shifted 
GFP). The GFPmutl proteins could be separated from the extracted cytoplasmic fraction by 
immobilized metal chromatography and yielded up to 2 mg of GFPmutl protein per liter of 
bacterial culture. The GFPmutl encoding plasmids were isolated from the most intensely 
fluorescing colonies and the two amino acid changes in the GFPmutl region, PheMtoLeu and 
Ser65 to Thr, were confirmed by DNA-sequencing. The cysteine residues on positions 48 and 
70 were conserved, despite the attempt to replace them. 
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~ °2 molecular weight markers (lane 3) or purified 
- 49 scFv-GFPmutl fraction (lane 4) were separated by 
- scFv-GFP SDS-PAGE, blotted to nitrocellulose and stained 
33 with GFP-specific antibodies. 
GFP- 28 
19 
The GFPmutl encoding genes were digested from the GFPmutl plasmids (Fig. 6.2A) and 
genetically fused to a gene encoding the scFv anti-LPS12 [8] (Fig. 6.2B) which is highly 
specific for the lipopolysaccharide of the bacterium ft solanacearum (biovar2, race 3). Upon 
induction with anhydrotetracycline clear green fluorescence could be measured intracellularly 
bacteria with the aid of a fluorometer. Further analysis showed that a green fluorescent 
compound was present in the periplasmic fraction. Purification of scFv-GFPmutl fusion 
proteins from the periplasmic fraction by immobilized metal affinity chromatography and 
subsequent analysis by Western blotting with GFP-specific antibodies showed an intensive 
band (Fig. 6.3, lane 4). With a molecular mass of approximately 45 kDa it was larger than the 
30 kDa observed for non-fused GFPmutl protein (Fig. 6.3, lane 1) but smaller than the 53 
kDa which was calculated using the scFv LPS12-GFP protein sequence. This phenomenon 
was probably the result of the formation of a functional chromatophore within the scFv-GFP 
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fusion protein and has been observed previously [2]. Support for this assumption was obtained 
as on Western blot, within a total lysate of the scFv-GFP producing bacteria, a major band of 
55 kDa was observed together with two additional bands of 47 and 45 kDa. The observed 
molecular masses correspond to 3 products of the scFv-GFPmutl fusion protein: scFv-
GFPmutl, preceded by the chloramphenicol acetyl transferase (CAT)-signal peptide (55 kDa); 
scFv-GFPmutl, preceded by the CAT-signal peptide with a functional chromatophore (47 
kDa) and the desired periplasmic secretion product scFv-GFPmutl, with an active 
fluorochrome but without the CAT-signal peptide (45 kDa). 
The quantity of the produced scFv-GFPmutl proteins was on average 100 ug per liter of 
bacterial culture. Replacement of the GFPmutl encoding sequence by GFPuv/mutl did not 
result in the expected improvement of expression and enhanced secretion of the scFv-GFP 
fusion protein to the periplasm, but rather lowered the yield. 
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Figure 6.4. Flow-cytometry analysis of the binding of GFPmutl to A) Ralstonia solanacearum 
bacteria and B) R. picketii bacteria and of the binding of fluobody scFv LPS 12-GFPmut 1 to C) R. 
solanacearum and D) R. picketii. 
The Afunctional character of the scFv-GFPmutl fusion proteins was shown by flow-
cytometry (Fig. 6.4). Comparable amounts of either non-fused GFPmutl protein or anti-
LPS12 fluobodies were applied to R. solanacearum bacteria. Binding, corresponding to a gain 
in immunofluorescence, was measured by flow-cytometry. The fluobodies showed, in contrast 
to the GFPmutl protein (Fig. 6.4A), bright fluorescent staining of the target bacteria (Fig. 
6.4C). This staining was specific as the negative control, R. picketii bacteria (closely related to 
R, solanacearum), was not stained with GFPmutl proteins (Fig. 6.4B) or with anti-LPS 12 
fluobodies (Fig. 6.4D). 
The applicability of the GFPmutl-scFv fusion proteins in IF was shown. Bright staining, 
comparable to a R. solanacearum specific polyclonal antiserum, of R. solanacearum bacteria 
was observed upon binding with anti-LPS 7 [7] fluobodies (Fig. 6.5). This reaction was 
specific because R. picketii bacteria were not stained by anti-LPS 7 fluobodies (data not 
shown). Moreover, in IF the advantage of fluobodies over FITC-conjugates was shown. While 
bacteria labeled with antibody-FITC conjugates were bleached completely after 4 min of 
illumination (Fig. 6.5B), bacteria labeled with fluobodies remained visible with a fluorescent 
microscope without any sign of bleaching (Fig. 6.5A). 
B 
Figure 6.5. Immunofluorescence cell staining of Ralstonia solanacearum bacteria using A) fluobody 
scFv LPS7-GFPmutl or B) FITC conjugated R. solanacearum specific polyclonal antiserum. 
Photographs were made after illumination of the objects for 20, 60 or 240 seconds, using the same 
photographic exposure time. 
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DISCUSSION 
Fluorescent antibodies, which can be applied for direct labeling in flow-cytometry or in 
immunofluorescence experiments, can be obtained from in vivo expression in E. coli bacteria. 
The restriction sites in the vector allow easy transfer of scFv-genes from phage display 
vectors like pHenl [11] and pCantab series (Pharmacia). 
The general yield of obtained fluobodies is not high. While for non-fused scFvs the 
maximum yield score of 3 mg per liter bacterial culture can be reached in shaker flasks under 
non-optimal conditions [8], the genetic fusion with GFPmutl drastically reduced the yield. 
This while under the same conditions the non-fused GFPmutl protein, when produced in the 
cytoplasm (i.e. without secretion to the periplasm), reached a yield of 2 mg per liter. In 
addition, when the same GFPmutl sequence was preceded by a signal sequence like pelB 
[17], the fluorescence dropped to a similar level as if a scFv was present. The use of another 
red-shifted GFP mutant (GFPuv/mutl) sequence, optimized for expression in E. coli, 
increased the yield when expressed as a non-fused protein in the cytoplasm. But when 
preceded by either a signal peptide alone or a signal peptide in combination with a scFv the 
yield also dropped, even to levels below those obtained with the GFPmutl protein. 
Apparently, the fast folding characteristics of the GFPuv/mutl mutant further lowers the 
ability of the protein to be secreted. 
It was anticipated that problems could arise after secretion of the scFv-GFP fusion proteins 
into the periplasmic space, as 2 cysteine residues are present in the wt-GFP protein. These 
cysteine residues normally do not form disulfide bonds in the wt-GFP but they might cause 
cross-links [28] with the cysteine residues of the scFv-domain. Therefore, the primer 
sequences were designed to replace those cysteine residues by serine, glycine or arginine. 
However, in all cases, DNA-sequencing revealed that both cysteine residues were conserved. 
As no non-fluorescing clones were sequenced it was not proved that both cysteine residues are 
required for the formation of a functional fluorochrome. It appeared that no internal disulfide 
bonds were formed between the scFv- and GFP-domains as the produced protein was able to 
bind to the target antigen and simultaneously to function as a highly stable fluorescent dye. 
High expression of scFv-GFP fusion proteins in the cytoplasm of E. coli might be possible 
as high yields were described for a genetic fusion of GFP with protein A [2]. This fusion 
protein was extracted by total disruption of the bacteria through sonic oscillation. For scFv-
GFP fusion proteins this is not favorable as the required disulfide bonds are not formed in the 
cytoplasm and thus extracted scFv would be unstable. However, secretion of GFP fusion 
proteins is possible, as was demonstrated by Oker-Blom and co-workers [20] for the genetic 
fusion of GFP with streptavidin. This GFP-streptavidin fusion protein was expressed at high 
yields in insect cells and appeared to be secreted into granules. Therefore, expression of 
fluobodies might give a better yield in insect cells or in other eukaryotic expression systems in 
which the folding and secretion of proteins is guided by more adequate chaperone proteins. 
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Although the GFP-streptavidin and GFP-Protein A fusion proteins have expression 
advantages over the scFv-GFP fusion protein, they require multiple incubation steps in 
immunoassays whereas scFv-GFP fusion proteins can be used in a single-step assay. 
Together, the data show that fluobodies are a promising tool as fluorescent reagents in 
immunoassays. Especially, since exploitation of fluobodies with other spectral characteristics 
might facilitate multiple labeling [1,33] of different epitopes simultaneously. 
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Chapter 7 
Discussion, Summary and Concluding remarks 
This thesis describes the applicability of the novel phage display technique to select plant-
pathogen-specific monoclonal antibodies (MAbs) from combinatorial antibody libraries. The 
retrieved MAbs are so specific that they can be used as diagnostic tools in sensitive 
immunoassays for the detection and identification of plant pathogens. Testing results, 
obtained from laboratories that have applied these recombinant MAbs, are discussed in this 
conclusive chapter. 
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Background 
In the last decades, it has become clear that chemical crop protection has to be reduced. Many 
of the pesticides, applied to destroy plant-pathogenic fungi, bacteria, insects and nematodes, 
are hazardous to the environment, and form a serious health risk for animals and humans. 
Since breeding for disease resistance generally takes years, epidemics have to be prevented by 
sanitary measures in combination with diagnosis in an early stage of disease development or 
preferably beforehand. Consequently, sensitive diagnostic assays are required that allow 
healthy plant propagation material to be certified and soil to be monitored. It is obvious that 
these data can be used to take adequate crop management decisions. 
The problems associated with serological detection of plant pathogens 
Immunoassays are widely applied as detection methods in agriculture because they can be 
applied to large numbers of samples, and their application is fast, robust, sensitive and cheap. 
A major concern is the specificity of the assays. Polyclonal antisera are still the active 
ingredient of many useful immunoassays. However, the immunochemical complexity of 
several target organisms is the main reason that extensive cross-reactions with non-target 
organisms can occur when these antisera are used. 
In 1975, Kohler and Milstein showed that this problem could be circumvented by making 
monospecific antibodies in continuous cultures by fusing the antibody producing B-
lymphocytes with myeloma cells [8]. This 'hybridoma' technique opened a new perspective 
for the production of specific monoclonal antibodies (MAbs) against various antigens. Today, 
many MAbs are used in research, as therapeutic agent and for diagnostic purposes. 
However, the hybridoma technique was not as advantageous as was expected in the field 
of plant-pathogen detection. From the trials in raising specific MAbs against many different 
plant-pathogens, it became apparent that there are 'difficult' antigens. Several plant viruses 
can not be sufficiently purified and contain immunodominant plant residues and, as a 
consequence, the immune response is mainly directed to those impurities. In addition, plant-
pathogenic bacteria, fungi and nematodes contain many epitopes that are 'shared' with closely 
related non-pathogenic family members, which is often leading to extensive cross-reactions. 
Therefore, the selection of the cells producing the desired MAbs is laborious and often 
impossible. 
Many techniques have been described to deal with 'difficult' antigens and varied from the 
enrichment of the desired B-cell populations to guiding of the immune response towards the 
target antigen, such as: 
• Immunoadsorption of antigen-specific B-cells [2]. 
• Selection of antigen-specific B-cells by fluorescence activated cell sorting [15]. 
• Complement-mediated lysis of undesired B-cells [2]. 
• Masking (immuno-complexing) of contaminating immunodominant plant epitopes with 
anti-healthy plant antibodies during immunization [2]. 
• Suppression of the immune response to healthy plant extracts by injection with 
cyclophosphamide or other immuno suppressive drugs prior to immunization [11,16]. 
• Induction of immunological tolerance through tolerisation of neonatal mice with healthy 
plant extracts prior to immunization [6]. 
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Although these methods have occasionally shown their value in obtaining specific MAbs in 
their respective cases, the common drawback of all these methods is that they are not 
generally applicable. In addition, the latter two are also repulsive from an ethical point of 
view. 
Bypassing immunization: A general solution to deal with 'difficult' antigens 
A way to circumvent immunization was offered by recent developments in recombinant DNA 
techniques [14,17]. These techniques allow cloning and expression of large naive antibody 
repertoires, derived from non-immunized human donors, in E. coli as single-chain antibodies 
(scFvs) or Fab fragments. The use of these combinatorial antibody libraries in combination 
with the display of functional antibody fragments at the tips of filamentous phage created a 
powerful selection system for MAbs [5,12]. Utilization of this phage display system allows 
direct selection of highly specific MAbs from naive combinatorial antibody libraries 
[3,13,18]. As immunization is omitted, phage display is not biased. Hence it will not lead to 
antibodies directed against the most immunodominant epitope but rather towards the most 
abundant antigenic determinant. 
Mission impossible: how to make the impossible possible 
Because application of the hybridoma technique was not successful in generating MAbs of 
sufficient specificity to detect the plant-pathogen Ralstonia solanacearum in reliable and 
sensitive diagnostic assays, the efficacy of the phage display system was challenged (Chapter 
2). To achieve this, phages derived from the (naive) Vaughan combinatorial antibody library 
(1.4 X 1010 different scFvs) were panned against purified lipopolysaccharides (LPS) which 
were isolated from R. solanacearum race 3 bacteria. After four successive rounds of phage 
growth and selection for LPS binding, soluble scFvs were produced and tested by enzyme-
linked immunosorbent assay (ELISA) and immunofluorescence microscopy (IF). Four 
different scFvs could be distinguished on bases of RFLP analysis. Characterization of the 
monoclonal scFvs against several bacterial strains, indicated a specificity for R. solanacearum 
(biovar 2, race 3) LPS which is higher than can be obtained with conventional polyclonal 
antisera. The fact that the four scFvs were obtained within six weeks after starting this study 
emphasizes the potency of the phage display system. 
Selection of specific antibodies from the synthetic Nissim library, containing over 108 
different scFv, against beet necrotic yellow vein virus (BNYVV) was achieved (Chapter 3) 
through expression of the antibody fragments on the surface of bacteriophage M13 and 
subsequent binding of this phage-antibody to immobilized BNYVV. After several rounds of 
selection seven BNYVV-specific recombinant monoclonal antibodies were obtained. 
However, the yield of these monovalent scFv antibodies was low. In an attempt to improve 
the yields, the genes encoding the BNYVV-specific scFvs were genetically fused to alkaline 
phosphatase (AP/S) and expressed in E. coli. However, out of the seven different anti-
BNYVV scFv-AP/S fusion proteins only three showed alkaline phosphatase activity and 
retained affinity for BNYVV and the quantity of produced scFv-AP fusion proteins was found 
to be low. 
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Analysis of scFv encoding DNA during expression in E. coli showed the occurrence of 
high plasmid loss and a high incidence of recombination within the scFv encoding DNA, both 
for scFv and scFv-AP/S fusion proteins. Probably the scFvs are toxic and offer bacteria that 
recombine the plasmid DNA (and thereby disable expression of scFvs) a growth advantage. 
The more tightly repressed tetracycline promoter was used to replace the "leaky" LacZ 
promoter (Chapter 4). The co-expressed repressor protein tightly repressed the tetracycline 
promoter in the absence of inducer (anhydrotetracycline). When this new expression system 
was compared to the old expression system (LacZ induction by IPTG) for expression of scFv-
AP fusion proteins, it was found to be superior as improved yields of functional recombinant 
antibodies were obtained. The tetracycline promoter is also more convenient to use. This is 
evident when large cultures or high numbers of cultures are grown because the medium has 
not to be changed since the use of this promoter is, unlike the LacZ promoter, glucose 
independent. 
Selection of tomato spotted wilt virus (TSWV)-specific scFvs from the naive Vaughan 
combinatorial antibody library (Vaughan) against purified nucleocapsids and against purified 
complete virus was also successful (Chapter 5). In contrast to previous selections the pooled 
scFv encoding DNA was isolated after the fourth round of selection, inserted in the vector 
pSKAP/S (Chapter 4) and tested directly as individual scFv-AP/S fusion proteins. Twelve 
different scFvs were obtained against the nucleocapsid (N) and five against the glycoproteins, 
Gl or G2. Six of the derived antibodies were produced with good yields: four scFvs against 
the nucleoprotein and two scFvs against Gl or G2. In ELISA they reacted with TSWV 
proteins in infected Nicotiana benthamiana and not with healthy plant extracts. When the N-
reactive scFvs were evaluated for their specificity against six other tospoviruses, cross-
reactions were observed with tomato chlorotic spot virus and to a lesser extent with groundnut 
ringspot virus. Several of the TSWV-reactive scFvs might be useful in routine testing, and an 
ELISA based on these recombinant antibodies is presently evaluated by routine testing 
laboratories. 
The ultimate goal 
The development of a sensitive double antibody sandwich ELISA format, based on 
recombinant antibodies, was a major objective. Whole antibodies coat very well to ELISA 
plates because they contain flexible hinge-regions that allow rotation of the antigen-binding 
site. However, scFvs are not suited for coating onto ELISA plates, as they are small molecules 
that are inactivated upon coating [7]. Fusion of scFv to immunoglobulin domains may 
enhance the coating efficiency while retaining the full binding activity. Therefore, N56, one 
of the TSWV binding scFvs, was transformed into a mini-antibody through addition of a 
constant part (Mouse K constant region) and a flexible dimerization domain (Chapter 5). 
These bivalent mini-antibodies proved to be very active as a coating reagent in ELISA 
(Chapter 5) and could compete with a conventional polyclonal antiserum for coating 
efficiency. As was shown in Chapter 5, sensitive detection of TSWV nucleocapsids could be 
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achieved by application of scFv-AP/S fusion proteins as antibody-enzyme conjugate. 
Therefore, serological testing can thus be carried out entirely by using bacteria derived 
coating and detection reagents. 
Endowing antibodies with novel properties 
Routine testing for R. solanacearum is currently mainly performed by immunofluorescent cell 
staining (IF). However, conjugation of antibodies with the fluorochrome fluorescein 
isothiocyanate (FITC) is not reproducible and FITC fades rapidly upon illumination. This is 
not the case with the product of he genetic fusion of R. solanacearum-specific scFvs with 
green fluorescent protein (GFP). Bright, specific fluorescent labeling of target bacteria was 
observed when the obtained scFv-GFP fusion proteins (fluobodies) were tested by flow 
cytometry and in IF. The fluobodies proved to be more resistant to illumination, as was shown 
by IF after prolonged illumination (Chapter 6). 
Table 7.1. Summary of testing the recombinant scFv alkaline phosphatase fusion protein (monoclonal) 
in comparison to polyclonal anti-Ralstonia solanacearum antiserum FITC or alkaline phosphatase 
conjugates. For ELISA the plates were coated with a R. solanacearum specific antiserum (pea 
9523bcd), blocked, incubated with samples (obtained from potato lots by PD regulations), incubated 
with either LPS7-AP/S or pca9523bcd-AP conjugate. 
potato samples 
N=206 
'NAK97 IF+, PD97+, 
Undiluted, N=19 
NAK97 IF+ ,PD97+, 
Diluted 1:10, N=17 
2Suspected, NAK97 IF±, 
PD97-,Undiluted, N=31 
Suspected NAK97 IF±, 
PD97-, Diluted 1:10, N=27 
3NAK97 Cross-reactions 
N=52 
Negative 
N=47 
PD negative control 
N=13 
9 
IF+ 
Typical 
100% 
100% 
16% 
15% 
0% 
0% 
0% 
[F-polyclonal 
IF+ 
Atypical 
0% 
0% 
13% 
11 % 
12% 
2 % 
0% 
IF-
0% 
0% 
71 % 
74% 
88% 
98% 
100 
% 
ELISA-
60 min 
OD>350 
100% 
94% 
32% 
19% 
4% 
0% 
0% 
polyclonal 
60 min 
OD<350 
0% 
6% 
68% 
81 % 
96% 
0% 
0% 
ELISA-monoclonal 
60 min 
OD>150 
100% 
100% 
26% 
15% 
0% 
0% 
0% 
60 min 
OD<150 
0% 
0% 
74% 
85% 
100% 
100% 
100% 
Samples were tested positive in 1997 and it was confirmed that they contained R. solanacearum 
bacteria. 
2Samples were tested positive in 1997 but did not contain R. solanacearum bacteria. 
'Samples were tested negative in 1997. 
Preliminary data of routine testing by diagnostic laboratories 
The R. solanacearum-spccific scFv, anti-LPS 7, was evaluated for its use in IF and in ELISA 
and was found to react with the same specificity as scFv LPS 12 (Chapter 2). It reacted with 
several R. solanacearum race 3 strains and showed cross-reactions with fewer strains than the 
polyclonal antiserum that is routinely applied for brown rot diagnosis of potato in the 
Netherlands. The general Netherlands inspection service for potatoes (NAK) evaluated the 
use of the anti-LPS7-AP/S based ELISA in their own laboratory and compared the results 
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with those obtained with IF. The samples, obtained and already tested by the Dutch Plant 
Protection Service (PD) and NAK in 1997, were derived from various potato varieties such as 
Agria, Bildstar, Bintje Cardinal, Desiree, Diamant, Dore, Elkana, Felsina, van Gogh, Kanjer, 
Karnico, L. Rossetta, Monalisa, Spunta, Stefano and Symphony. The extraction of bacteria 
was performed according to the regulation of the PD and the results, summarized in Table 7.1, 
show that IF and ELISA gave comparable results for detection. Moreover, the ELISA that 
utilizes scFv-AP/S fusion proteins for detection is comparable with the polyclonal ELISA, but 
more importantly, the background is lower when the recombinant antibody is used for 
detection instead of the polyclonal alkaline phosphatase conjugate. No problems of increased 
background were observed regarding the sampling from the different potato varieties. The 
reduced number of cross-reactions that was observed for the recombinant antibodies in 
Chapter 2 also seems to hold for this field trial, as the number of positive samples found 
within the pool of suspected and cross-reacting samples was reduced. It can therefore be 
concluded that the recombinant scFv LPS7 is very useful under real testing conditions. 
General conclusion and future perspectives 
This thesis shows that antibody phage display is a useful technique for the selection of 
specific recombinant antibodies against a variety of plant-pathogens. Thus far, recombinant 
antibodies have been selected only against viruses and bacteria. The results described are 
promising, and it is expected that the phage display technique can also be used successfully 
for raising specific MAbs against fungi and nematodes. Therefore, the perspective that was 
predicted after introduction of the hybridoma technique in 1975 [8], now becomes reality with 
application of the novel antibody phage display technique. 
Although the synthetic naive Nissim library (108) was not compared directly to the naive 
Vaughan library (1010), the obtained results favor the application of the latter. The variability 
within the retrieved scFv-antibodies was higher and the yield of the scFvs was better. 
Moreover, the amount of scFv-AP/S fusion protein required for a strong signal in the ELISA 
was up to 50-fold lower, indicating that the recombinant antibodies retrieved from the 
Vaughan library were of higher affinity. In general, it can be stated that large (>1010) naive 
antibody libraries are a prerequisite for generating useful recombinant antibodies. 
More than 50 different antigen-specific recombinant antibodies were selected without the 
use of experimental animals. However, screening the selected scFv-antibodies was a major 
problem since E. coli produced several of those, only with great difficulty. It remains 
disappointing that the choice of a scFv for further characterization was based more on its 
yield, than on its affinity and specificity for the antigen. Development of eukaryotic 
expression systems might be an option. Yeast, insect-cells, fungi and plants resemble more 
closely the mammalian cells than the prokaryotic bacterium E. coli with regard to protein 
expression, and improved yields of functional scFv-antibodies can be expected when 
eukaryotes are used. 
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There is an ongoing improvement of selection techniques from combinatorial antibody 
phage display libraries such as selectively infective phage [1,9], expression of antibodies on 
ribosomes [4] and selectively infected bacteria [10]. Meanwhile, combinatorial phage display 
libraries are designed to give better folding, and consequently, better producing antibodies. 
When these novel techniques find their way into plant pathology, it will undoubtedly result in 
highly specific antibodies that can be used in diagnostic assays that are fast, reliable, robust 
and cheap. 
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Samenvatting 
Achtergrond 
In de laatste decennia is het steeds duidelijker geworden dat het gebruik van chemische 
bestrijdingsmiddelen sterk verminderd moet worden. Veel van deze pesticiden zijn zeer 
belastend voor het milieu en vormen een gezondheidsrisico voor mens en dier. Het is dus zaak 
om milieuvriendelijke methoden te ontwikkelen om de plantenziekten in de hand te houden. 
In dit verband is het van belang dat het uitgangsmateriaal (knollen, bollen, zaad en ent-
materiaal) vrij is van plantenpathogenen. Het optreden van ziektes zal dan in de regel 
achterwege blijven en de bestrijding van ziektes is niet of veel minder nodig. Voorts kan door 
het toetsen van grondmonsters informatie verkregen worden die te gebruiken is voor advies 
met betrekking tot gewasrotatie, cultivar selectie, toepassing van pesticiden, moment van 
oogsten en nabehandeling van het geoogste gewas. 
Toetsmethoden 
Voor het opsporen van ziekteverwekkers (plantenpathogenen) zoals bijvoorbeeld virussen, 
bacterien, schimmels, insecten of parasitaire nematoden in zaaigoed, planten of grond, zijn 
betrouwbare toetsingsmethoden nodig. Er moet immers met zekerheid vastgesteld kunnen 
worden of plant- of grondmonsters besmet zijn of niet. Een methode die vaak wordt gebruikt, 
werkt met behulp van antilichamen uit het serum van dieren die opzettelijk zijn ingespoten 
met het betreffende plantenpathogeen. De dieren worden hier zelf niet ziek van, maar 
produceren wel grote hoeveelheden zogenaamde antilichamen. Deze antilichamen kunnen 
vervolgens in een serologische toets worden gebruikt (Fig. 1). Dergelijke serologische toetsen 
zijn niet alleen toepasbaar op grote aantallen monsters, ze zijn bovendien snel, robuust en 
goedkoop. 
Specificiteit van ons afweersysteem 
Bepaalde bacterien, virussen en schimmels zijn in staat om mens en dier ziek te maken. 
Meestal wordt de patient na korte tijd weer beter. Dit komt omdat bepaalde cellen (witte 
bloedlichaampjes) van het afweersysteem op de ziekteverwekker reageren door onder andere 
antilichamen te maken tegen een scala aan structuren (epitopen) van deze lichaamsvreemde 
stoffen. Deze polyklonale antilichamen worden vervolgens afgegeven aan het bloed en 
kunnen de ziekteverwekker elders in het lichaam herkennen en deze vervolgens vernietigen. 
De lichaamscellen, die de antilichamen produceren, hebben een geheugenfunctie. Als je 
eenmaal de mazelen gehad hebt, krijg je gedurende de rest van je leven nooit meer mazelen. 
Dat andere ziekteverwekkers nog steeds kunnen toeslaan komt doordat de antilichamen, die 
gemaakt zijn tegen het mazelenvirus, bijvoorbeeld het griepvirus niet herkennen. Een antistof 
heeft dus een bepaalde specificiteit. Omdat ziekteverwekkers in talloze soorten en variaties in 
de natuur voorkomen beschikt het afweersysteem dan ook over een groot aantal verschillende 
antilichamen, elk met een andere specificiteit. Er wordt geschat dat het afweersysteem meer 
dan 1 miljard antilichamen kan maken, elk met een verschillende specificiteit! 
103 
o 
• •! • 
Figuur 1. Een schematische weergave van een serologische toets. Extracten van gezonde planten (A) en zieke 
planten (B) worden gekoppeld aan het oppervlak van een vaste drager. Vervolgens worden antilichamen tegen 
de ziekteverwekker toegevoegd. Als de ziekteverwekker aanwezig is zal de antistof aan de ziekteverwekker 
binden (B). Deze binding is zo sterk dat na grondig wassen alle antilichamen die bij de gezonde plant werden 
toegevoegd (A) worden weggewassen (C) maar niet bij de zieke plant (D). Na het wassen wordt een chemische 
stof toegevoegd. Deze stof is kleurloos (O)maar wordt door het enzym alkalische fosfatase (AP) dat gekoppeld 
is aan de antistof omgezet in een kleurstof ( • ) . De zieke planten zijn dus detecteerbaar door een kleuromslag in 
de test. 
Helaas zijn de polyklonale antilichamen die in het bloed aanwezig zijn vaak niet specifiek 
genoeg om toegepast te kunnen worden in een detectiesysteem. Ze zijn niet gericht tegen een 
bepaalde epitoop van de ziekteverwekker maar tegen een breed scala daarvan. Enkele van die 
structuren kunnen ook voorkomen bij andere, vaak onschadelijke, organismen die dikwijls 
aanwezig zijn in de directe omgeving van de plant. Het is dus zaak om alleen die antilichamen 
te produceren, die onderscheid kunnen maken tussen zieke en gezonde planten. 
Productie van antilichamen in de reageerbuis. 
Technisch is het mogelijk om de geactiveerde antistof-producerende cellen van het 
afweersysteem te isoleren en ze te kloneren doormiddel van een celfusie met kankercellen. 
Hoewel er bij een dergelijke celfusie vele duizenden antistof-producerende cel-klonen 
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ontstaan, is dit aantal in veel gevallen toch niet toereikend om hieruit een kloon te selecteren 
die antilichamen met de vereiste specificiteit produceert. In de praktijk blijkt namelijk vaak 
dat het selecteren van een kloon die de gezochte specifieke antistof produceert vergelijkbaar is 
met het zoeken van een naald in een hooiberg. De inefficiente celfusie en de eigenschap van 
het afweersysteem, om juist tegen sommige epitopen sterk te reageren en tegen andere niet, 
liggen hieraan ten grondslag. 
Recombinant-DNA techniek: de uitkomst! 
Een uitkomst voor deze problemen werd geboden door de toepassing van moderne 
recombinant-DNA technieken. Deze technieken maakten het mogelijk om het genetische 
materiaal, dat de blauwdruk vormt voor de antilichamen, over te brengen van de antistof 
producerende cellen naar bacterien. Dit resulteerde uiteindelijk in zogenaamde antilichaam-
bibliotheken die de blauwdrukken bevatten voor meer dan 10 miljard verschillende 
antilichamen. Deze blauwdrukken kunnen hier naar believen uitgehaald worden door de 
bacterien te infecteren met een bacterie-virus (bacteriofaag). Tijdens de vermeerdering van 
het virus in de bacterie neemt deze niet alleen een blauwdruk voor een antistof in zich op 
maar met behulp van de bacterie wordt deze antistof ook geproduceerd en vervolgens aan het 
oppervlak van het virus ingebouwd. Na een strenge selectie uit deze miljarden verschillende 
bacteriofagen op specificiteit kan dit uiteindelijk een monoklonaal antilichaam opleveren 
welke gebruikt kan worden om de gezonde van de zieke plant te onderscheiden. Een 
bijkomend voordeel is dat voor de selectie van deze monoklonale antilichamen geen 
proefdieren meer nodig zijn. 
Toetsen op plantenpathogenen 
Het hoofdonderwerp van dit proefschrift is de productie en selectie van plantenpathogeen 
specifieke monoklonale antilichamen, die bruikbaar zijn in serologische toetsen. Daarbij 
werden met behulp van recombinant-DNA technologie monoklonale antilichamen 
geselecteerd die specifiek gericht zijn een tegen plantenpathogeen zoals de bacterie Ralstonia 
solanacearum (biovar 2, race 3), de veroorzaker van bruinrot bij de aardappel (Hoofdstuk 2) 
en het "beet necrotic yellow vein virus" (BNYVV), de veroorzaker van rhizomanie bij de 
suikerbiet (Hoofdstuk 3). Verder is er aandacht besteed aan de optimalisatie van productie en 
toetsing van de geselecteerde monoklonale antilichamen (Hoofdstuk 4). Deze optimalisatie 
werd vervolgens toegepast op de selectie van recombinante antilichamen, die gericht zijn 
tegen het tomatenbronsvlekkenvirus (TSWV, Hoofdstuk 5). Dat een recombinante antistof 
een handig stuk gereedschap vormt dat gemakkelijk gemanipuleerd kan worden werd 
aangetoond door middel van de productie als fusie-eiwit met het enzym alkalische fosfatase 
(Hoofdstuk 3 en Hoofdstuk 4) en als een fluorescerend eiwit (Hoofdstuk 6). 
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